Stockwinners Market Radar for November 01, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

21:23 EDT Cathie Wood's ARK Investment bought 208.9K shares of Recursion Pharmaceuticals

19:43 EDT Teva announces publication of efficiency/safety findings for UZEDY in The Lancet - The company stated: "Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd, announced the publication of efficacy and safety findings from the phase 3 Risperidone Subcutaneous Extended-Release, or RISE, study in The Lancet Psychiatry. The data supported the FDA approval for UZEDY, which was approved in April 2023 for the treatment of schizophrenia in adults as a subcutaneous injection every one or two months using a pre-filled syringe. In RISE, UZEDY significantly prolonged time to impending relapse by 5.0 times with once-monthly dosing and 2.7 times with once-every-two-months dosing versus placebo in patients with schizophrenia, corresponding to a decreased risk of relapse by 80% and 62.5%, respectively. Study findings also show UZEDY provided clinically relevant plasma concentrations within 24 hours of administration and maintained them over the flexible dosing intervals. Additionally, the observed safety profile of UZEDY was consistent with other approved formulations of risperidone - reinforcing its potential role as an effective LAI treatment option for adults living with schizophrenia. In the RISE study, 544 patients were randomized to receive a subcutaneous injection of UZEDY once-monthly (n=183), once-every-two-months (n=180), or placebo (n=181).1 In this study population, 59% were Black or African American (n=322), 38% White (n=206), 22% were Hispanic or Latinx (n=117), 1% were Asian (n=7), less than1% were Native Hawaiian or other Pacific Islander (n=2), less than1% did not report a race (n=3), and less than1% were considered other race (n=4)."

19:38 EDT Ashford Hospitality reports Q3 occupancy at about 72% - Ashford Hospitality Trust "reported that the Company expects to report Occupancy of approximately 72% for the third quarter of 2023 with Average Daily Rate of approximately $182 resulting in RevPAR of approximately $132. This Comparable RevPAR reflects an approximate increase of 4% compared to the third quarter of 2022. Additionally, for the month of July 2023, Comparable RevPAR increased approximately 3% versus July 2022. For the month of August 2023, Comparable RevPAR increased approximately 5% versus August 2022. For the month of September 2023, Comparable RevPAR increased approximately 4% versus September 2022."

18:51 EDT ITT to acquire Svanehoj for $395M - ITT Inc "announced it has signed an agreement to acquire privately held Svanehoj Group A/S for about $395M. The transaction is expected to close in the first quarter of 2024, subject to the receipt of customary regulatory approvals. Svanehoj will become part of ITT's Industrial Process segment, a global leader in flow focused on highly engineered pumps, valves and aftermarket services. Headquartered in Svenstrup, Denmark, Svanehoj is a supplier of pumps and related aftermarket services with leading positions in cryogenic applications for the marine sector. Its product portfolio primarily consists of deepwell gas cargo pumps, fuel and energy pumps and tank control systems. These products manage critical liquids for the energy transition, including ammonia, liquefied petroleum gas, liquefied natural gas, methanol, hydrogen and CO2, and are widely regarded as the highest quality offering across most verticals. Svanehoj also has an established global aftermarket business to service its large installed base and is capable of servicing third-party equipment as well."

18:09 EDT Unity director sells $16.2M in common stock - In a regulatory filing, Unity disclosed that its director David Helgason sold 643K shares of common stock on October 30th in a total transaction size of $16.2M.

18:00 EDT eCargo secures distribution contract with Nestle - eCargo Holdings announced that it has been appointed as Nestle's cross-border master distributor for China for its Coffee and Dairy range. Under the agreement, eCargo will help Nestle to sell its coffee and dairy products, which includes Nestle Gold, Starbucks coffee and Milo, in Mainland China through cross-border channels, providing supply chain, distribution, eCommerce and digital marketing solutions. The cross-border trade management is facilitated by Flow, eCargo's proprietary platform providing B2B supply chain solutions including buyer-supplier management, international logistics, and credit management.

17:58 EDT Zoom Video CFO Steckelberg sells $655K in company shares - The Chief Financial Officer of Zoom Video, Kelly Steckelberg, disclosed the sale of 10,960 shares of company stock at $59.73 per share on October 30, for a total transaction amount of $654,657.

17:51 EDT MYR Group announces new $75M share repurchase program - MYR Group announced a new share repurchase program, Repurchase Program.The Repurchase Program authorizes the Company to repurchase, in the aggregate, up to $75M of its outstanding shares of common stock from time to time on the open market or in privately negotiated transactions in accordance with applicable federal securities laws. The Repurchase Program will expire on May 8 or when the authorized funds are exhausted, whichever is earlier. The Company intends to fund the Repurchase Program with cash on hand and through borrowings under its credit facility. The Repurchase Program was authorized by the Board of Directors and will be effective on November 9. The Company's prior $75M repurchase program that commenced on May 9 is scheduled to expire on November 8.

17:40 EDT Avis Budget appoints Izzy Martins CFO, Brian Choi Chief Transformation Officer - Avis Budget Group announced significant changes within its leadership team, reinforcing the company's commitment to its strategic vision and long-term success. Effective January 1, Izzy Martins, currently serving as EVP Americas, will assume the role of EVP & Chief Financial Officer, succeeding Brian Choi, who will take on the newly established position of EVP & Chief Transformation Officer. Martins has been with Avis Budget Group for nearly 20 years in various senior strategic and financial roles, including Chief Financial Officer, Americas, Chief Accounting Officer and most recently EVP Americas, where she obtained a wealth of operational expertise through her responsibilities for the Americas region. Choi's appointment as EVP & Chief Transformation Officer underscores Avis Budget Group's commitment to leveraging data, analytics, and cutting-edge technology to enhance the customer experience, revenue management, and overall operational performance. Mr. Choi has served as the company's EVP & Chief Financial Officer since August 2020. Joe Ferraro, Chief Executive Officer of Avis Budget Group, said, "Izzy's deep financial acumen coupled with her operational expertise will ensure a seamless transition into the CFO role. She is a key strategic partner to me, the Board, and the leadership team, and has been instrumental to our success over the years.

17:33 EDT QuidelOrtho says 'confident' in ability to deliver on revenue growth targets - Says strong performance across all geographies, including China. Remains "bullish" on China. Says China business "fine, expected to be a growth driver." Expects high teens growth in China business in FY23. Says strong respiratory demand in key markets in Q3. Says strong order book, winning contracts. Says deleveraging remains a "key priority." Says "very confident" of strong finish to year. Comments taken from Q3 earnings conference call.

17:30 EDT Aris Water Solutions sees Q4 adjusted EBITDA of $41M to $4, below prior guidance - The company states: "We are very pleased with the progress the team has made year-to-date and we are on track to achieve the high-end of the Adjusted EBITDA guidance we provided at the beginning of the year and affirmed last quarter. As we look to the fourth quarter, we anticipate produced water volumes to be up approximately 2-3%, adjusting for the impact of the Martin County asset sale, and water solutions volumes to be down moderately sequentially versus the third quarter due to the pull-forward of activity we saw in the third quarter as well as potential seasonal year-end slowdowns."

17:26 EDT Canadian National acquires stake in Cape Breton & Central Nova Scotia Railway - CN announced that it acquired from Genesee & Wyoming Inc., a stake in the Cape Breton & Central Nova Scotia Railway that includes 145 miles of active track. The CBNS railway, which interchanges with CN's mainline at Truro, Nova Scotia, will continue to be operated by a Genesee & Wyoming Inc. subsidiary. This will ensure a seamless, safe, and efficient continuation of service for customers. The CBNS railway, which interchanges with CN's mainline at Truro, Nova Scotia, will continue to be operated by a Genesee & Wyoming Inc. subsidiary. This will ensure a seamless, safe, and efficient continuation of service for customers.

17:23 EDT Jakks Pacific jumps 18% to $20.11 after Q3 results

17:22 EDT Northern Oil and Gas narrows FY23 production view to 97K-99K boe/d from 96K-100K

17:20 EDT Tandem Diabetes names Mark Novara as EVP and Chief Commercial Officer - Tandem Diabetes "announced the appointment of Mark Novara as Executive Vice President and Chief Commercial Officer, effective November 13, 2023. Mr. Novara comes to Tandem with extensive global healthcare experience, having served in the diabetes, medical technology, and life sciences industries for nearly 25 years."

17:16 EDT Pennant Group acquires Guardian Hospice, terms undisclosed - Pennant Group announced that it has acquired Guardian Hospice and Guardian Hospice of Oklahoma, which provides skilled hospice services in Grayson, Fannin, Collin, Cook, Denton, and Hunt counties in Texas, and Bryan, Choctaw, Atoka, Pushmataha, Johnston, Coal, Marshall, Murray, Pontotoc, and Love counties in Oklahoma.

17:11 EDT Electronic Arts up 5% at $129.83 after Q2 earnings beat

17:10 EDT Park Hotels & Resorts declares 77c per share special cash dividend - Park's board of directors declared a special cash dividend of 77c per share in connection with the effective exit from the Hilton San Francisco Hotels, which results in a required additional distribution. The special dividend will be paid on January 16, 2024 to stockholders of record as of December 29.

17:05 EDT Four Corners Property Trust reports Q3 rental revenue up 17% y/y at $57.2M

17:02 EDT Inari Medical to acquire LimFlow in up to $415M deal - LimFlow SA announced that it has entered into a definitive agreement to be acquired by Inari Medical, a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases. Under the terms of the agreement, LimFlow will receive $250 million in cash at closing and be eligible to receive up to $165 million in additional payments based on certain commercial and reimbursement milestones, for a total potential transaction value of up to $415 million. The transaction is expected to close in the fourth quarter of 2023.

17:00 EDT Rocky Brands says inventories down 26.5% from last year

16:57 EDT SilverBow Resources sees Q4 output 353-375 MMcfe/d - The company stated: "For the fourth quarter of 2023, SilverBow is guiding to estimated production of 353-375 MMcfe/d, with expected oil volumes comprising 16,400-17,000 Bbls/d or 28% of total production at the midpoint. For full year 2023, the Company is guiding to a production range of 336-342 MMcfe/d, with expected oil volumes of 13,900-14,100 Bbls/d or 25% of total production at the midpoint. Based on guidance, SilverBow's full year 2023 oil production is expected to increase roughly 94% year-over-year, with oil/liquids comprising 40% of the total production mix in the fourth quarter of 2023. The Company also increased its free cash flow guidance for full year 2023 to a range of $20-$40 million."

16:53 EDT ACRES Commercial Realty Corp. CFO David Bryant to retire - ACRES Commercial Realty Corp. announced that David Bryant, Senior Vice President, CFO and Treasurer, is retiring from ACR, effective December 31, 2023. Bryant has faithfully served the company for 17 years. Bryant joined ACR as Senior Vice President, CFO, Chief Accounting Officer and Treasurer in June 2006 and has played a significant role in the design and execution of the company's strategy. Effective January 1, 2024, Eldron Blackwell will succeed Bryant as Senior Vice President, CFO and Treasurer. Blackwell has served as Vice President and Chief Accounting Officer of the company since March 2014, leading the company's accounting and financial reporting functions.

16:50 EDT Costco reports October SSS ex gas/FX up 3.1% - Costco Wholesale Corporation reported net sales of $18.53B for the retail month of October, the four weeks ended October 29, an increase of 4.5% percent from $17.73B last year. For the first eight weeks of the fiscal year ended October 29 , the Company reported net sales of $36.57B an increase of 5.3% from $34.74B for the first eight weeks of fiscal year 2023 ended October 23. Reports October Comparable sales excluding the impacts from changes in gasoline prices and foreign exchange 3.1%.

16:49 EDT Aflac COO Frederick Crawford to retire, effective September 30, 2024 - Aflac announced that Frederick Crawford, President; COO of Aflac will retire effective September 30, 2024.

16:47 EDT BioMarin names Alexander Hardy CEO, succeeding Jean-Jacques Bienaime - BioMarin Pharmaceutical (BMRN) announced that Alexander Hardy has been named president and CEO, succeeding Jean-Jacques Bienaime, who will retire as chairman and CEO effective December 1, 2023. Hardy, currently the CEO of Genentech, will also serve as a director on BioMarin's board of directors. Richard Meier, BioMarin's lead independent director, will assume the role of chair of the board of directors. Hardy brings more than 30 years of experience in the global healthcare and biotechnology industries, most recently serving as CEO of Genentech, a member of the Roche Group (RHHBY).

16:45 EDT Openlane sees FY23 adjusted EPS 60c-70c, consensus 65c - The company's previously stated annual guidance for Adjusted EBITDA and operating adjusted net income from continuing operations per diluted share remains unchanged.

16:44 EDT Marathon Oil raises quarterly base dividend to 11c per share

16:43 EDT HP Enterprise selected to deliver U.K.'s fastest supercomputer - As part of the UK Government's investment in a national AI Research Resource, The University of Bristol and Hewlett Packard Enterprise announced that HPE has been selected to deliver the UK's fastest supercomputer thanks to GBP225M of Government funding.

16:41 EDT Ingevity announces further repositioning of Performance Chemicals business - Ingevity president and CEO, John Fortson today announced a number of strategic actions designed to further reposition the company's Performance Chemicals segment. "What we are doing today is an important step toward achieving our strategic objectives of improving the profitability and reducing the cyclicality of the Performance Chemicals business and the company as a whole," said Fortson. "Today's actions increase our focus on growing our most profitable Performance Chemicals businesses such as Pavement Technologies and accelerate our transition to non-crude tall oil (CTO)-based fatty acids (AFA). Our decision is the result of a careful evaluation of various strategic options to address the cyclicality of our rosin-based end markets, as well as the significant structural changes and elevated pricing of CTO due to the biofuels market. Going forward, we will continue to strengthen and diversify the Performance Chemicals business through the introduction and expansion of complementary and new product offerings based on alternative chemistries, such as soy and canola-based fatty acids." Today's announcement includes the permanent closure of the company's DeRidder, Louisiana, production facility that manufactures a range of CTO-based products that are primarily for the Industrial Specialties business, which is reported within Ingevity's Performance Chemicals segment. Ingevity expects to close the DeRidder facility by the end of the first half of 2024. The company also announced additional corporate and business cost reduction actions, which combined with those previously announced, are expected to result in total annual savings of $65-75 million beginning in 2024. As a result of the Performance Chemicals repositioning, Ingevity expects to incur aggregate charges of approximately $280 million, consisting of approximately $180 million in asset-related charges, approximately $15 million in severance and other employee-related costs and approximately $85 million in other restructuring costs, which include decommissioning, dismantling and removal charges and contract termination costs. The company expects approximately $180 million of the total charges to be non-cash. The majority of non-cash charges and 50-60% of cash charges are expected to be recognized by the end of the first half of 2024. Employees affected by today's announcement include approximately 180 people at the DeRidder facility and approximately 120 people in business and support functions. Together with the actions taken earlier in 2023, headcount reductions represent almost 20% of Ingevity's global workforce.

16:38 EDT Disney to buy remaining 33% stake in Hulu from Comcast, sees paying $8.61B - The Walt Disney Company (DIS) announced that it will acquire the 33% stake in Hulu, LLC held by Comcast Corp.'s (CMCSA) NBC Universal, following Comcast's November 1 exercise of its right under the put/call arrangement between the two companies. "The acquisition of Comcast's stake in Hulu at fair market value will further Disney's streaming objectives," Disney stated. Under the terms of the put/call arrangement, by December 1, Disney expects it will pay NBCU approximately $8.61B, representing NBCU's percentage of the $27.5B guaranteed floor value for Hulu that was set when the companies entered into their agreement in 2019 minus the anticipated outstanding capital call contributions payable by NBCU to Disney. Under the appraisal process agreed to by Disney and Comcast, Hulu's equity fair value will be assessed as of September 30, 2023, and if the value is ultimately determined to be greater than the guaranteed floor value, Disney will pay NBCU its percentage of the difference between the equity fair value and the guaranteed floor value. "While the timing of the appraisal process is uncertain, we anticipate it should be completed during the 2024 calendar year," Disney added.

16:36 EDT Warrior Met Coal sees FY23 capex for existing mines $95M-$105M - The Company's "guidance for its capital expenditures consists of sustaining capital spending of approximately $95 - $105 million, including regulatory and gas requirements, and capital spending of $325 - $380 million for the development of the Blue Creek reserves and other discretionary capital expenditures such as final payments on two new sets of longwall shields originally purchased in 2022, and the final 4 North bunker construction. The Company currently expects discretionary capital expenditures in 2024 to be less than 2023 and mainly consist of the development of the Blue Creek reserves, which is subject to change."

16:33 EDT Murphy USA cuts FY23 CapEx view to $325M-$375M from $375M-$425M - The Company is taking the opportunity to update specific guidance metrics initially provided in January. Due to ongoing challenges in permitting new sites, contractor delays, and other supply chain hurdles, the forecast is now 27-30 new stores to open in 2023, versus the "up to 45" in the original guidance. The Company successfully redirected capital to slightly increase raze-and-rebuild activity, planning to end the year at 33 stores, above the initial guidance of "up to 30" stores. Accordingly, as some of the growth capital is deferred into 2024 due to delays in new store growth, the expected range of capital expenditures should approximate $325 million to $375 million, from $375 million to $425 million previously.

16:30 EDT Unifi reports Q1 EPS (73c) vs (44c) last year - Reports Q1 revenue $138.844M vs $179.519M last year. Eddie Ingle, Chief Executive Officer of Unifi, Inc. said, "Our performance in the first quarter of fiscal 2024 reflects a continuation of the weak demand and depressed ordering patterns impacting the apparel industry and its supply chains. Given the current challenges facing the industry, our customers have continued to take a cautious approach to placing new orders as they work through existing inventory levels and monitor consumer activity. Such inventory appears to be approaching pre-pandemic levels, giving us confidence that we may soon experience improved order flow. Despite the difficult environment, our disciplined cost control measures enabled us to generate solid cash flows during the quarter and reduce net debt."

16:30 EDT Sterling Bank announces partnership with Rocket Companies - Sterling Bank and Trust, F.S.B., the wholly owned subsidiary of Sterling Bancorp, Inc. (SBT) announced a partnership with Rocket Mortgage, America's largest retail mortgage lender and a part of Rocket Companies (RKT). The partnership will offer Sterling customers a fully digital home loan experience, providing homebuyers with a convenient and easy way to purchase or refinance a home. Christine Meredith, Senior Executive Vice President and Chief Risk Officer, described the partnership as a strong option for Sterling's customers who would like to become a homeowner or tap into their home's equity. "Rocket Mortgage has earned more J.D. Power awards for client service than any other home lender. This gives us confidence that Rocket's tech-driven and simplified mortgage experience is the best choice for Sterling customers and is a perfect fit with our ongoing mission to find opportunities that make banking easy for our customers."

16:28 EDT Herbalife sees at least $60M of cost savings realized in 2023

16:24 EDT CareDx announces CEO transition - CareDx "announced that Dr. Reginald Seeto will be stepping down from his position as Chief Executive Officer and President and resigning as a Director of the Board effective November 1, 2023, and will transition to the role of Senior Advisor to the Chairperson. CareDx will establish an Office of the CEO consisting of Board Chairperson Michael Goldberg, Chief Financial Officer Abhishek Jain and President of Patient and Testing Services Alexander Johnson. The Board of Directors has initiated a search for a permanent CEO and is considering both internal and external candidates."

16:22 EDT VA American Water files rate request driven by $110M in investment - Virginia American Water filed a general rate application today with the State Corporation Commission (SCC) requesting recovery of $110 million in capital investments between May 2023 and April 2025, to continue providing safe and reliable service. The company continues to make needed investments to replace aging infrastructure, comply with water quality and environmental regulations, and meet customers' other water and wastewater service needs. The filing includes the acquisition of the water and wastewater assets of the Town of Cape Charles and the drinking water assets of E.L. Goddard Inc. "Our approach of long-term, consistent investments in both our water and wastewater systems helps maintain the quality of service our customers expect today and in the future. As a company, we believe that the service we provide must be safe and comply with EPA regulations and Safe Drinking Water Act standards; reliable, so that it is resilient in the face of floods, droughts, and other weather-related risks; and affordable," said Barry Suits, Virginia American Water president. "One of the steps we are taking to address the issue of affordability is proposing a universal affordability tariff in our request to help keep rates affordable and expand our low-income discount program."

16:21 EDT Williams sees FY23 adjusted EBITDA between $6.6B-$6.8B - The company increased its midpoint of guidance and now expects 2023 Adjusted EBITDA between $6.6 billion and $6.8 billion. Growth capex guidance remains the same; between $1.6 billion to $1.9 billion. Importantly, Williams anticipates a leverage ratio midpoint of 3.65x, which will allow it to retain financial flexibility. The dividend was increased by 5.3% on an annualized basis to $1.79 in 2023 from $1.70 in 2022.

16:17 EDT PayPal reports Q3 TPV $387.7B

16:16 EDT Rayonier announces capital structure realignment plan - Rayonier announced an asset disposition and capital structure realignment plan targeting $1 billion of select asset sales over the next 18 months. The proceeds of the asset sales will be used to reduce the Company's leverage to less than or equal to3.0x Net Debt / Adjusted EBITDA* and return meaningful capital to shareholders. The Plan is intended to enhance shareholder value by capturing the significant disparity between public and private timberland values and reducing the level of debt the Company maintains in a higher interest rate environment. The Plan will also improve the Company's competitive positioning by divesting less strategic assets and concentrating capital in markets with the strongest cash flow attributes and most favorable long-term growth prospects. The Company today announced the first step toward effectuating the Plan with the sale of 55,000 acres in Oregon for $242 million. "Rayonier remains committed to its nimble, value-added capital allocation strategy," said David Nunes, Chief Executive Officer. "The disconnect between private market timberland values and the Company's public market valuation is at an historically wide level, and the plan announced today will allow us to take advantage of this opportunity to create value for our shareholders as well as right-size our leverage to the current market environment. Our portfolio scale and pure-play timber REIT structure afford us the flexibility to take these initiatives, and we are confident that they will result in meaningful value accretion for our shareholders."

16:15 EDT Rayonier names Mark McHugh president and CEO - Rayonier announced that David Nunes will be retiring as Chief Executive Officer and a member of the Board, effective March 31, 2024. Pursuant to a multi-year succession planning process led by the Board of Directors, Mark McHugh, currently President and Chief Financial Officer, will become CEO and join the company's Board at that time. "Serving as Rayonier's CEO over the past nine years has been extremely fulfilling," said Mr. Nunes. "We emerged from the spin-off of our specialty pulp manufacturing business to become the leading pure-play timber REIT, growing the size and quality of our timberland portfolio while also launching a successful real estate development business. I'm very proud of the culture that we've built at Rayonier and very excited about the growth opportunities that lie ahead for the company and its next generation of leadership."

16:13 EDT Etsy sees Q4 GMS down in the low single digit range y/y - "GMS for Q4 2023 is currently estimated to decline in the low-single-digit range on a year-over-year basis. However, if trends worsen, that could become a mid-single-digit decline, and if trends improve GMS could be flat or even up slightly year-over-year. We estimate Q4 2023 take rate to be approximately 20.8%, down slightly on a sequential basis due to normal seasonality. This can be used to estimate revenue range for the quarter. Adjusted EBITDA margin for Q4 2023 is currently estimated to be between 26-27%."

16:10 EDT 4DMT provides data from Phase 1/2 AEROW trial of aerosolized 4D-710 for CF - 4D Molecular Therapeutics announced interim data from the Phase 1/2 AEROW clinical trial evaluating aerosolized 4D-710 for treatment of cystic fibrosis lung disease. Results will also be presented at the 2023 North American Cystic Fibrosis Conference NACFC in both plenary and symposium sessions on November 2-3. "We are pleased with the safety and tolerability of 4D-710 in participants in the AEROW study to date. Participants with cystic fibrosis in this clinical trial do not have the option of treatment with currently available disease modifying therapies and therefore have high unmet need," said Jennifer L. Taylor-Cousar, M.D., MSCS, Professor, Departments of Medicine and Pediatrics, and Co-Director, Adult Cystic Fibrosis Program, Director, Cystic Fibrosis Foundation Therapeutics Development Center, National Jewish Health and lead Principal Investigator in the AEROW clinical trial, "By delivering copies of the CFTR?R transgene to the lung epithelium with a novel aerosolized AAV and achieving high levels of CFTR protein expression in airway cells, 4D-710 has the potential to provide durable benefit in these individuals and potentially all individuals affected by CF."

16:09 EDT Roku reports Q3 active hours up 2.3% from last year - The company states: "Active Accounts were 75.8 million, a net increase of 2.3 million Active Accounts from Q2 2023. Streaming Hours were 26.7 billion, up 4.9 billion hours YoY. Average Revenue Per User (ARPU) was $41.03 (trailing 12-month basis), down 7% YoY"

16:01 EDT SolarEdge trading halted, news pending

15:56 EDT MercadoLibre rises into close after apparent early release of earnings - Shares of MercadoLibre trading in New York are up 7% into the close after Bloomberg reported that the company posted Q3 net revenue of $3.76B, which topped the $3.56B estimate. The shares gained after the report of the revenue beat. Earnings are due out after the close from MercadoLibre.

14:15 EDT Six Flags, Cedar Fair rise following reports of potential merger - Shares of Six flags (SIX) and Cedar Fair (FUN) are on the rise following news reports saying that an agreement between the two could be unveiled this week. According to Wall Street Journal's Lauren Thomas and Will Feuer, Six Flags is nearing a deal to merge with Cedar Fair Entertainment, a move that would combine two of the largest regional-theme-park chains in the U.S. The companies have discussed a combination in the past, including in 2019, and there is no certainty that the latest deliberations will result in an agreement, Reuters' Greg Roumeliotis and David French also report, citing sources close to the matter. PRICE ACTION: In Wednesday afternoon trading, shares of Six Flags have jumped over 8% to $21.58, while Cedar Fair has gained about 6% to $37.67.

13:17 EDT Walgreens Boots Alliance names Neal Sample as Chief Information Officer - Walgreens Boots Alliance named Neal Sample as its new Executive Vice President and Chief Information Officer, or CIO, effective immediately. "Sample will report to Tim Wentworth, Chief Executive Officer (CEO) of WBA, as a member of the Executive Committee and serve on the IT Governance Committee. He has been working alongside WBA technology leaders over the course of the last month to assess and advance the company's technology goals. Moving forward, he will lead the strategy for WBA's IT function and the implementation of its technology and digital innovation, with an emphasis on improving the digital experience for customers and patients, as WBA continues its next phase of growth into a customer-centric healthcare company," the company stated. Sample currently serves as Chairman of the Board at Wellfield Technologies, as well as the Chair of the Board of Trustees for the University of Health Sciences and Pharmacy, and was previously the CIO for Northwestern Mutual.

13:15 EDT Acme United trading resumes

12:53 EDT Mazda reports October U.S. sales down 7.2% to 23,504 vehicles - Mazda North American Operations reported total October sales of 23,504 vehicles, a decrease of 7.2% compared to October 2022. Year-to-date sales totaled 296,121 vehicles, an increase of 23% compared to the same time last year. With 25 selling days in October, compared to 26 the year prior, the company posted a decrease of 3.5% on a daily selling rate basis.

12:33 EDT Acme United trading halted, news pending

12:24 EDT Endeavor Group up 1% to $23.03 following Bloomberg report

12:15 EDT Hyatt on track to double brand footprint in Canada by 2026 - Hyatt Hotels is positioned to double Hyatt's brand footprint in Canada by the end of 2026, with more than 20 executed managed and franchised agreements across its distinct brands. As Hyatt continues to build industry-leading net rooms growth globally, this strategic and intentional growth in Canada reflects Hyatt's focus on listening and developing in destinations that matter most to guests, World of Hyatt members and owners. With nearly 20 hotels currently open in Canada, Hyatt expects to have an additional 23 hotels open and operating by the end of 2026, doubling Hyatt's Canadian brand footprint, and further expanding compelling guest and member experiences for World of Hyatt, one of the industry's fastest growing loyalty programs. This significant expansion includes newly announced deals for luxury and lifestyle hotels including the second hotel in Canada within The Unbound Collection by Hyatt brand. The hotel will be located in Ontario wine country and will join Spirit Ridge located in the beautiful Okanagan Valley wine country

12:01 EDT North European Oil Royalty Trust falls -20.9% - North European Oil Royalty Trust is down -20.9%, or -$2.28 to $8.64.

12:00 EDT Paycom falls -37.3% - Paycom is down -37.3%, or -$91.35 to $153.62.

12:00 EDT Scotts Miracle-Gro rises 18.9% - Scotts Miracle-Gro is up 18.9%, or $8.39 to $52.84.

11:52 EDT Barfresh Food Group regains compliance with Nasdaq requirement - Barfresh Food Group received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market, informing the Company that it has regained compliance with the minimum stockholders' equity requirement set forth in Nasdaq Listing Rule 5550(b)(1). As previously announced, the Company was notified by Nasdaq on May 3, 2023 that it was not in compliance with the minimum stockholders' equity requirement set forth in Nasdaq Listing Rule 5550(b)(1). On June 14, 2023, the Company received a letter from Nasdaq granting the Company an extension through October 30, 2023 to regain compliance with the Rule. In the Form 10-Q for the quarter ended September 30, 2023, the Company reported that it had issued convertible notes in the amount of $1,390,000, and that note balances of $1,207,000 were immediately converted into approximately 820,000 shares of common stock. A pro-forma balance sheet was presented in the Form 10-Q giving effect to the October 23, 2023 note issuance and conversion, showing that the Company satisfies the stockholders' equity requirement on a pro-forma basis as of September 30, 2023 and as of October 26, 2023. The proceeds from the convertible notes increased stockholders' equity to meet the requirement and were not required to support the growth of the company. Subscribers to the note include the Company's CEO and founder, Riccardo Delle Coste, and the Company's existing strategic investor Unibel SA, a recognized global leader in innovation, branding, retail and manufacturing.

11:04 EDT Box, Google Cloud expand partnership for generative AI - Box, Inc. (BOX) announced an expanded partnership to transform work in the enterprise with generative AI. Box will integrate with Vertex AI to build new gen AI features that help customers more efficiently process and analyze data stored in the Box Content Cloud (GOOG, GOOGL), which is also now available to customers directly through Google Cloud Marketplace.

10:57 EDT reAlpha Tech Corp trading resumes

10:27 EDT Monro enters exclusive supply agreement with Valvoline - Monro (MNRO) disclosed that on October 31, the company entered into a supply agreement with Valvoline (VVV), effective November 1. Under the Agreement, Valvoline will continue as the exclusive supplier of the motor oils, greases, lubricants and certain other related products Monro uses at its retail locations. The agreement will be in effect until October 31, 2026.

10:21 EDT Falcon's Beyond Global Inc trading resumes

10:19 EDT ServisFirst Bank names Michael Lindsey chief information, operations officer - ServisFirst Bank announced the addition of Michael Lindsey as Chief Information and Operations Officer in Birmingham, Alabama. Most recently, Lindsey has been with Equipro Holdings, LLC since 2015, a privately held firm dedicated to building companies in Oxford, Mississippi. During this time, he held prominent positions as the President of US Consumer Capital, LLC, and also served as the Chief Operating Officer for Action Auto, LLC.

10:08 EDT Ree Automotive regains compliance with Nasdaq minimum bid price requirement - REE Automotive Ltd. received a notification letter from Nasdaq Listing Qualifications staff notifying the company that it had regained compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rule 5550(a)(2). The notification letter confirmed that REE maintained a closing bid price at or greater than $1.00 per ordinary share for the last 10 consecutive business days from October 18, 2023 to October 31, 2023 and that the company has regained compliance with the Nasdaq Capital Market Minimum Bid Price Requirement.

10:01 EDT Custom Truck One Source opens new location in North Dakota - Custom Truck One Source announced the opening of its newest location in Williston, ND, adding capacity to the Company's existing footprint in North America. The two-story Williston facility sits on more than three acres, offering more than 10,000 square feet of service capacity, designed to support the needs of Custom Truck's rental fleet and equipment clientele across the Upper Midwest.

10:00 EDT Estee Lauder falls -19.9% - Estee Lauder is down -19.9%, or -$25.65 to $103.22.

10:00 EDT Generac rises 12.4% - Generac is up 12.4%, or $10.43 to $94.50.

10:00 EDT Mercury General rises 12.9% - Mercury General is up 12.9%, or $3.98 to $34.86.

09:54 EDT Atlassian urges customers to take 'immediate action' to protect against bug - Atlassian on Tuesday warned of a critical security flaw that could lead to "significant data loss" for customers, just weeks after state-backed hackers targeted its products. The company urged customers to patch against the flaw affecting on-premise versions of Atlassian Confluence Data Center and Server. The company said: "As part of our continuous security assessment processes, we have discovered that Confluence Data Center and Server customers are vulnerable to significant data loss if exploited by an unauthenticated attacker. There are no reports of active exploitation at this time; however, customers must take immediate action to protect their instances. Please read the Critical Security Advisory below for instructions and vulnerability details. Protecting customers' instances is our top priority, and our prompt response demonstrates our dedication to ensuring the safety of our customers and your data. Atlassian is always reviewing security measures to reduce security risks and support our customers in taking timely action. Customers can expect to receive high-priority patches outside of our monthly advisory schedule as necessary. We believe that taking proactive action is the best approach and we appreciate your ongoing partnership." Reference Link

09:47 EDT MasTec falls -18.2% - MasTec is down -18.2%, or -$10.84 to $48.60.

09:47 EDT Axalta Coating rises 10.5% - Axalta Coating is up 10.5%, or $2.75 to $28.98.

09:47 EDT Generac rises 13.6% - Generac is up 13.6%, or $11.46 to $95.53.

09:41 EDT Constellation Energy completes acquisition of stake in Texas nuclear plant - Constellation (CEG) announced that it has completed its acquisition of NRG Energy's (NRG) 44% ownership stake in the South Texas Project Electric Generating Station, a 2,645-megawatt, dual-unit nuclear plant located about 90 miles southwest of Houston. Constellation's stake represents approximately 1,100 megawatts of the plant's output. The ownership transfer was approved on October 30 by the Nuclear Regulatory Commission, which was the final regulatory approval needed before closing the deal. "Growing our fleet of the nation's best-run nuclear plants is at the heart of our growth strategy," said Joe Dominguez, president and CEO of Constellation. "As the world is waking up to the immense value of nuclear power to address the climate crisis and maintain energy security, Constellation will continue to look for opportunities to expand our ownership of assets like STP. We look forward to working with our new co-owners and the plant's team members to provide reliable, clean and affordable energy, as well as economic benefits to the people of Texas."

09:41 EDT ShiftPixy trading resumes

09:40 EDT EyePoint Pharmaceuticals trading resumes

09:36 EDT Sotera Health trading halted, volatility trading pause

09:33 EDT Nautilus rebrands as BowFlex - Nautilus becomes BowFlex, adopting a name synonymous with home fitness for nearly 40 years. "BowFlex has produced some of the most innovative strength and cardio equipment the home fitness industry has seen in the last few decades - from our popular SelectTech adjustable strength products to our VeloCore bike and Max Trainer line," said Jim Barr, CEO at BowFlex Inc. "Today, BowFlex is inspiring customers to embrace their inner and outer strength - and as a consumer-led company, that ethos is reflected through our enduring mission, and in the products we develop. Becoming BowFlex Inc. is a natural evolution of our company as we continue to create connected fitness experiences for our customers, through our entire family of brands, including BowFlex, Schwinn, and JRNY." The corporate rebranding is the latest step in the company's digital transformation, in alignment with its North Star strategy. In addition to the name change, the company's New York Stock Exchange symbol has changed to BFX from NLS, also effective 11/1.

09:30 EDT EyePoint Pharmaceuticals trading halted, volatility trading pause

09:24 EDT Verses AI 'endorses' White House executive order on AI - VERSES AI provides commentary from Founder and CEO Gabriel Rene on the recently announced White House AI Executive Order on Safe, Secure and Trustworthy Artificial Intelligence. "We were very encouraged to see the issuance of this Order," said Gabriel Rene, founder and CEO of VERSES. "For the past two years, we have been developing the IEEE socio-technical standards as tools to help ensure that AI systems are safe, secure, trustworthy and privacy-preserving. Our report, 'The Future of AI Governance,' offers a unique perspective on global artificial intelligence governance that combines the legal expertise of the world's largest law firm, Dentons, the AI acumen of VERSES and guidance on socio-technical standards from the Spatial Web Foundation.

09:18 EDT OrthoPediatrics launches MP+ Bar for clubfoot - OrthoPediatrics announced today the limited release of the Mitchell Ponseti Plus Bar as part of their Specialty Bracing portfolio for kids with clubfoot. The new MP+ Bar features several innovations from their traditional Bar, which was originally launched in 2004. The company is currently developing the MP Lite boots & bar system, which will be available in markets outside the United States.

09:16 EDT Zynex approves $20M share repurchase program - Zynex announced that its board of directors approved a program to repurchase up to $20.0M of the Company's common stock. The program will commence on November 1 and is scheduled to terminate on the earlier of November 1, 2024, or when the $20.0M limit is reached. The Company expects to finance the purchases with existing cash balances.

09:15 EDT Skyward Specialty Insurance announces additional expansion in surety division - Skyward Specialty Insurance announced additional expansion in its surety division, marked by the strategic recruitment of the industry's top Surety talent. Skyward Specialty welcomed Scott Bailey as vice president of Field Operations for Contract Surety. Mr. Bailey has nearly 40 years of experience specializing in Surety. He began his career at Travelers Bond and Specialty Insurance and held expanded leadership roles at Merchants Bonding Company, Frankenmuth Surety and United Fire & Casualty. Additionally, the Company recruited Chaz Cointment as assistant vice president of Contract Surety who will lead the expansion of the Company's contract surety presence across Texas and surrounding states. Throughout his more than 15-year career, Mr. Cointment has established a reputable market presence through various leadership positions at Travelers Bond and Specialty Insurance, RLI, Inc., and Nationwide. Alongside these significant leadership roles, the company welcomed five senior underwriters. They include Derek Leppek, formerly of Crum & Forster, Tom Langhurst, previously with United Fire Group, and Marlena Guay from Liberty Mutual Surety, all of whom will enhance opportunities in Contract Surety. Additionally, Kyle Mineo from AON, PLC and Alexandra Kiely, previously with Traveler's Insurance Company, have joined the team to bolster expansions in Commercial Surety.

09:14 EDT Verisk Analytics estimates industry insured losses from Hurricane Otis - Verisk estimates industry insured losses to onshore property for Hurricane Otis will likely fall from MXN 50 billion to MXN 110 billion, or ~USD 3 billion to 6 billion). The industry loss range includes insured estimates of wind and precipitation-induced flood across Otis's track. Most of the modeled loss is attributable to wind. Hazard and Damage Observations: Few wind measuring stations survived the storm and provided reliable data on wind speeds. One station near Acapulco that endured the storm recorded a peak wind gust of 135 mph. Observations from aircraft as well as satellite data were used to help constrain the modeled windfield. Maximum rainfall amounts along the coast generally fell between 8 and 12 inches, with a widespread 2+ inches across much of the state of Guerrero. Damage to coastal and inland exposures in and around Acapulco was catastrophic. Insurance take up for residential risks is quite low in Mexico, though a bit higher for commercial risks. However, it is likely there is higher residential insurance take up in Acapulco, particularly in direct coastal areas, than across the rest of the state of Guerrero. Included in the industry insured loss estimate are losses to onshore residential, commercial and industrial properties and automobiles for their building, contents and time element coverage from wind and precipitation induced flood.

09:13 EDT LPL Financial: Pathway Wealth joins broker-dealer, RIA, custodial platforms - LPL Financial announced that financial advisors John Lankford and Justin Pestel, CPFA, of Pathway Wealth Advisors have joined LPL Financial's broker-dealer, RIA and custodial platforms. They reported having served approximately $125 million in advisory, brokerage and retirement plan assets, and join LPL from Woodbury Financial, part of Osaic. Based in Wichita Falls, Texas, Pathway Wealth Advisors was founded with a singular mission to help clients work toward their financial goals and the life they've always envisioned through structurally sound financial planning. Lankford and Pestel are the second generation of Pathway owners, following the footsteps of founders Shirley Donnell and Phillip Brooks. They are joined by Client and Services Assistant Regina Dingmon.

09:11 EDT LegalZoom announced its new business license product - LegalZoom announced its new business license product, which helps businesses become compliant and operate legally. This new product is built on a proprietary nationwide database and a delightful customer experience that matches a small business profile with relevant licenses and permits. LegalZoom's nationwide database is kept up-to-date down to the local level of requirements. The business license product supports business owners by removing the time-consuming and often confusing process of researching and discovering requirements. "Business owners can save hours and enjoy peace of mind with our personalized technology that connects them to our extensive database of licenses, permits, and registrations, so they know what's required by the federal, state, county, and local governments to become and remain compliant," said Dan Wernikoff, CEO at LegalZoom.

09:10 EDT MEI with Anson and Cable Car announce cooperation pact, $1.75 p/s dividend - MEI Pharma and Anson Funds and Cable Car Capital or Anson and Cable Car announced that they have entered into a cooperation agreement. Key terms of the agreement include: Capital Return to Stockholders: The Company intends to promptly pay a dividend in the amount of $1.75 per share of common stock to all stockholders. Additionally, a second return of capital of approximately $9.33M in the aggregate will be authorized by the Board if either at least 17 patients in Cohort 1 of the Company's ongoing ME-344 phase 1b study have disease progression prior to week 16 of treatment, a threshold consistent with the bar set forth in the phase 1b clinical trial protocol needed to continue the study by enrolling Cohort 2 of the phase 1b study, or at least six months after the date of the cooperation agreement, and prior to the initiation of Cohort 2 of the phase 1b study, the Company's Board determines not to proceed with Cohort 2. This second return of capital may take the form of a dividend or tender offer, will be subject to the proper exercise by the Board of its fiduciary duties under applicable law and is subject to modification to the extent necessary to comply with appliable requirements under Delaware law.

09:09 EDT Lexicon receives coverage from Express Scripts on its basic, high formularies - Lexicon Pharmaceuticals announced that Express Scripts, the pharmacy benefits management business of The Cigna Group's Evernorth, has determined that it will place INPEFA on its Basic and High Performance formularies for commercially insured patients as of today, November 1, 2023, and in addition to the previously reported Premier Access and Premier Performance national formularies for Medicare patients. These formulary placements will provide access to INPEFA for Express Scripts commercial and Medicare patients in plans that utilize these formularies and who meet the parameters of INPEFA's FDA-approved indication. "We continue to make progress in establishing access and reimbursement for INPEFA and are pleased by the Express Scripts decision announced today," said Lonnel Coats, Lexicon's chief executive officer. "We continue to work toward our goal of broad access to and coverage for INPEFA, with this being the latest of a series of coverage decisions."

09:08 EDT Working Not Working launches NTRNL talent tool - Working Not Working launched NTRNL, a new way to source internal talent and showcase hidden employee passions and expertise for creative ventures and projects. NTRNL allows employees to create human-centered and highly personalized profiles, highlighting their project portfolio, skills, and interests while providing companies with greater visibility into their team's expertise, passions, and willingness to join new and exciting projects. Following Wieden+Kennedy being the company's first customer over ten years ago, they are also the first official launch partner of NTRNL. NTRNL's advanced search and sourcing capabilities allow any creative organization to find employees for the right projects from its entire workforce - regardless of location, title, or experience. NTRNL also facilitates collaboration throughout an increasingly global workforce, effectively allowing employees to connect based on shared interests and fostering a sense of belonging across team members. The platform can help accelerate new business opportunities by tapping into otherwise unknown employee interests, skills, and experience beyond their day-to-day work. NTRNL will bring together the best teams and give employees more access to the opportunities they care about most.

09:07 EDT Clover Health promotes Karen Soares to general counsel - Clover Health announced the appointment of Karen Soares as General Counsel, effective October 31, 2023. Karen will serve on Clover's management team and will report to Andrew Toy, Chief Executive Officer of Clover. Soares first joined Clover in 2018 as an Associate General Counsel, supporting the contracting, compliance, and product functions.

09:06 EDT GT Biopharma sees cash runway into 2H24 - The Company had cash, cash equivalents and short-term investments of $16.01 million as of September 30, 2023 compared to $17.97 million as of June 30, 2023. We expect ample runway to fund operations into 2H 2024.

09:03 EDT Synchrony announces new partnership with GreatWater 360 Auto Care - Synchrony announced a new partnership with GreatWater 360 Auto Care to provide customers multiple customized financing options to help pay for maintenance and repairs of their vehicles. Through this partnership, GreatWater 360 Auto Care joins the Synchrony Car Care network, enabling GreatWater customers to use its private label credit card at all GreatWater locations in the U.S. as well as the more than one million gas stations and auto parts and service businesses nationwide. Through this partnership, GreatWater 360 Auto Care joins the Synchrony Car Care network, enabling GreatWater customers to use its private label credit card at all GreatWater locations in the U.S. as well as the more than one million gas stations and auto parts and service businesses nationwide.

09:02 EDT Hyundai Motor America reports October sales of 60,805 units, up 0.3% y/y - Hyundai Motor America reported total October sales of 60,805 units, a 0.3% increase compared with October 2022. This is the 15th month in a row Hyundai has seen increases in total sales. Hyundai set total sales records in October for Elantra HEV (+15%), IONIQ 5 (+89%), Santa Fe HEV (+81%), Tucson PHEV (+170%) and Tucson HEV (+14%). Hyundai also announced the Winter Sales Event of 0.0% APR Financing* for up to 60 Months plus 90-days deferred on 24MY Tucson ICE and 23MY Santa Fe ICE and HEV for well-qualified buyers.

08:54 EDT Atara Biotherapeutics announces restructuring and 30% workforce reduction - Concurrent with the execution of the global tab-cel partnership, Atara is undertaking a strategic restructuring and is reducing its current workforce by approximately 30% This will enable Atara to execute its remaining responsibilities under the tab-cel collaboration with Pierre Fabre Laboratories, while focusing on the advancement of ATA188 and its differentiated allogeneic CAR T programs The strategic restructuring, combined with certain anticipated payments from the expanded global partnership and the Company's existing cash, cash equivalents and short-term investments as of September 30 is expected to fund the Company's planned operations into Q3...The ATA188 Phase 2 EMBOLD study primary analysis and communication remains on track for early November with more than 90 patients to be included

08:52 EDT 1847 Cabinets expands relationship with leading homebuilder - 1847 Holdings announced that its subsidiary, 1847 Cabinets Inc., a designer, manufacturer and installer of cabinets, doors and millwork for residential construction, has entered into an expanded agreement with one of the nation's largest homebuilders, as its exclusive provider of windows for all new residential construction projects in the Reno, Nevada, metropolitan area.

08:52 EDT Yum! Brands sees FY23 tax rate 20% - Sees FY23 core operating profit up low double digits. Expects $10M loss at Habit grill in Q4. Sees Q4 G&A slightly lower. Says digital sales set record. Says Taco Bell will enhance loyalty program starting next year. Says taco bell delivered another quarter of exceptional performance. Comments taken from Q3 earnings conference call.

08:50 EDT Vivakor evaluating acquisitive, organic growth opportunities - Vivakor is pleased to provide a Shareholder Update, from its Chairman and Chief Executive Officer James Ballengee. "I write to you today with gratitude, pride and excitement. Gratitude and pride for the dedication and support of our employees, partners and shareholders in our accomplishments to date, and great excitement for the value I see for us in the path ahead. Since our strategic acquisition in Q3 2022 of our two gathering facilities, Silver Fuels Delhi in Louisiana and Colorado City close to Midland, Texas, the Company has had several significant milestones in the growth of our business. In Q4 of 2022, I was appointed as Chairman and CEO of the Company. I am an established energy industry entrepreneur having successfully sold three oil and gas companies over the past several years for an aggregate value of approximately $1 billion. With my relationships and track record, I believe I am well-positioned to maximize the value of Vivakor's patented technologies and business opportunities. In Q1 of 2023, we added two new independent members to the Company's Board of Directors that also have oil and gas experience to support our Company's endeavors, namely John R. Harris and Albert Johnson. In addition, we added an additional independent member to our Board of Directors, David Natan to chair our Audit Committee, and added Tyler Nelson, our Chief Financial Officer, to our Board of Directors both of which strengthen the accounting experience on our Board of Directors...Due to our successful trial results, the Company was able to borrow $1.9 million USD from DIC to move the RPC that was originally located in Utah (RPC II) to Kuwait so that both RPCs may work on the project in Kuwait. RPC II is currently en route to Kuwait and is expected to arrive before the end of the year. The Company is expecting to receive a license fee of $20 per ton and operational costs of the RPC are expected to be covered by DIC. Management is expecting the RPCs to process as much as 40 tons per hour based on the volume of feedstock supplied. Overall, we believe that the KERP project contains as much as 26 million tons of contaminated material. We plan to maximize the RPC technology with partners and capital from the Middle East for the purpose of creating a low-risk revenue and profit stream for the Company. With the successful trials, and the movement of RPCII to Kuwait, we believe the first steps have been accomplished in this endeavor. The RPCs have been financed via Special Purpose Vehicles that were structured to allow the SPV investors of the RPCs to take advantage of the depreciation and participate in the gross revenue from oil sales. Currently, the SPV participants receive up to 25% of the gross revenues from oil sales. Management feels that in the current financial market it would make sense to continue these types of financings to accelerate the Company's expansion of RPCs for current and future projects. This enables the Company to have access to capital that will be less dilutive in nature to the Company shareholders and decrease the need for capital from the current markets that tends to be very dilutive in nature and, together with extreme warrant coverage, has negatively impacted many companies' market capitalizations. At such time, when the Company has sufficient cashflows or access to less dilutive capital, it can then exercise its right to buy out the SPV investors, if one exists, and collect all of the revenues being generated from the RPCs. The Company has moved RPC II from the Utah site but still maintains the lease for the property in Utah. We believe this is still an opportunity for the Company and plan to explore it at a later date. The RPC Houston project has hit many significant milestones. In Q4 of 2022, the Company finalized the lease of approximately 3 three acres close to Lake Houston. In Q1 of 2023 an SPV closed its offering, netting approximately $13.7 million for the manufacture of facilities to process up to 40 tons of material at the Houston site. We were able to prepare the facility to process and store both the tank bottom sludge and other contaminated soil that it will be receiving along with the cleaned soil and recovered oil from its remediation process. In addition, the Company, in Q2 2023, closed on a $2.2 million debt financing to expand the Houston site to add a washout facility. The addition of the washout capability will allow Vivakor's Houston facility to offer a full-service remediation center for the producers of the tank bottom sludge. With this addition of the wash plant, we anticipate customers will be able to drop off contaminated waste for remediation into sellable, reclaimed oil, and have their trucks and containers cleaned for reuse in the same facility. Construction of the RPC in Houston is nearly complete and the wash plant is in the latter stages of construction. We are currently waiting on permits from the Texas Railroad Commission and the EPA to allow us to operate the facility. We anticipate those to be approved in the near future and to begin processing samples shortly after receiving the permits. We believe the Houston site provides a tremendous opportunity for the Company. The current, estimated going rate for accepting hazardous waste such as tank bottom sludge is $400-$500 per ton and current wash fees can run as much as $2,000 per truck with all of its containers. Once the waste is taken in, we believe that we will be able to recover and reuse at least 1.3 barrels of oil per ton of waste. It is our goal to set up similar facilities in the years to come and reclaim and recycle millions of barrels of oil per year. Overall, management will endeavor to apply technologies to assist the world in its transition to green energy and in that process will deploy different strategies and assets needed to accomplish this goal. If you have any questions, please see our filings with the SEC."

08:47 EDT CureVac announces progress in Phase 2 COVID-19, Seasonal Flu programs - CureVac announced solid progress in its clinical vaccine development programs in COVID-19 and seasonal flu, conducted in collaboration with GSK. In the joint COVID-19 development program, recruitment of the ongoing Phase 2 study was completed at 427 randomized participants after the first participant was dosed in August 2023 . The study assesses the safety and immunogenicity of different single booster doses of two modified mRNA COVID-19 vaccine candidates: the monovalent candidate, CV0601, encoding the spike protein of the omicron BA.4-5 variant and the bivalent candidate, CV0701, encoding the spike protein of the omicron BA.4-5 variant as well as the original SARS-CoV-2 strain. Vaccine candidates are compared to a licensed or authorized bivalent COVID-19 comparator vaccine. Interim Phase 2 data are expected in early 2024. In the joint seasonal flu development program, the first participant was dosed in the Phase 2 part of the combined Phase 1/2 study, following selection of a promising vaccine candidate based on positive Phase 1 interim data announced September 12, 2023. The potentially differentiated, multivalent candidate encodes antigens matched to all WHO-recommended flu strains. It was selected from the Phase 1 part of the study that compared a comprehensive series of multivalent, modified mRNA seasonal flu vaccine candidates with up to eight separate mRNA constructs per candidate. In Phase 2, the selected candidate will be tested in younger and older adults at different dose levels compared to age-appropriate licensed seasonal flu comparator vaccines. Data are expected in 2024.

08:45 EDT Hudson Global announces acquisition of Hudson Global Resources - Hudson Global announced the acquisition of Hudson Global Resources. Hudson Singapore has a 30-year track record of senior placements and project recruitment work across Southeast Asia including Singapore, Malaysia, the Philippines, Vietnam, Thailand, and Indonesia. "We are very excited to welcome the Hudson Singapore team to Hudson RPO and believe this accretive combination will generate considerable value for our clients, team, and stockholders," said Jeff Eberwein, Chief Executive Officer of the Company. "We believe a multi-service, total talent strategy consisting of recruitment services, contracting, project work, RPO, and MSP is essential to accelerate our growth in Asia, where RPO adoption has lagged that of other regions, and Hudson Singapore brings to Hudson RPO the complement of capabilities needed to execute on this strategy. Together, we believe we can achieve our Asia growth goals through cross-selling Hudson RPO's services among Hudson Singapore's diverse, blue chip client base as well as leveraging our recognition as a larger, full-service Asia enterprise to win new business and gain share in this important market."

08:43 EDT IO Biotech presents three posters at SITC meeting - IO Biotech announced three poster presentations at the Society for Immunotherapy of Cancer's 38th Annual Meeting, SITC, being held in San Diego, California from November 1-5, 2023. "The data presented provide clear evidence that our immune modulating vaccines, developed based on our T-win technology platform, impact several immune escape mechanisms as elegantly exemplified in abstract #1468," said Mai-Britt Zocca, PhD, President and Chief Executive Officer of IO Biotech. "The data in this poster demonstrate enhanced in vivo anti-tumor effect when IDO and PD-L1 vaccines are co-administered in these models, further supporting the clinical observations regarding our lead investigational therapeutic vaccine candidate, IO102-IO103, which targets IDO and PD-L1. Data from clinical trials of IO102-IO103 administered with a PD-1 inhibitor demonstrated enhanced anti-tumor activity in multiple tumor types, including metastatic melanoma, non-small cell lung cancer and squamous cell cancer of the head and neck."

08:42 EDT Curiosity Ink Media expands Santa.com's e-commerce offerings - Curiosity Ink Media, Intellectual Property-generating subsidiary of Grom Social Enterprises, joined forces with two special partners, Sweet Tooth Fairy and Denik, to release exclusive, branded gift options on its dynamic holiday destination, Santa.com. A high-utility resource, the site is a solution for the busiest and most stressful time of the year, helping families with offerings, including home goods, journals, calendars, stationery items, as well as some of Santa's favorite candy and baked goods.

08:41 EDT Blockchain Intelligence Group signs one-year agreements - BIGG Digital Assets announced a significant milestone in Blockchain Intelligence Group's growth and global expansion strategy. Blockchain Intelligence Group has signed 1 year agreements with both a prominent foreign government agency and a law enforcement organization, for an aggregate value of up to C$150,000, paving the way for new revenue scales and further global expansion.

08:40 EDT BioSig Technologies adds five new patent awards to 100+ patent portfolio - BioSig Technologies announced that the U.S. Patent and Trademark Office has awarded several new utility patents covering the Company's PURE EP digital signal processing technology. Kenneth Londoner, Chairman and CEO of BioSig, commented, "We are pleased to add five utility patent awards to our expanding intellectual property portfolio of more than 100 patents and patent applications in the U.S. and abroad. Our robust patent protection and well-constructed claims cover BioSig's first mover advantage for our novel PURE EP Platform." New Patent Awards: U.S. Patent Application No. 16/543,061 was allowed on September 22, 2023 and is entitled "Systems and Methods To Display Cardiac Signals Based on a Signal Pattern." U.S. Patent No. 11,737,699 granted on August 29, 2023 and is entitled "Systems and Methods for Performing Electrophysiology Signal Processing." U.S. Patent No. 11,737,701 granted on August 29, 2023 and is entitled "Methods, Systems and Media For Reconstructing Bioelectric Lead Placement." U.S. Patent 11,617,529 granted on April 4, 2023 and is entitled "Apparatus and Methods for Removing a Large-Signal Voltage Offset from a Biomedical Signal." U.S. Patent 11,617,530 granted on April 4, 2023 and is entitled "Apparatus and Methods for Removing a Large-Signal Voltage Offset from a Biomedical Signal."

08:38 EDT Lexaria Bioscience expands studies of proprietary platform - Lexaria Bioscience announces the availability of a broadcast titled, "Can Diabetes, Weight-Loss Drugs Get Even Better?" The company said, "It shouldn't be surprising that analysts at Markets and Research estimate the global diabetes drug market at $63.1 billion in 2021 on its way to $82.93 billion in 2027, while the global market for diabetes devices was valued at another $26.1 billion and growing 7.5% annually. Due to the pain and unpleasantness of injections, many diabetes sufferers prefer to treat their condition with drugs rather than devices, if they have the choice. Some of the most popular type 2 diabetes in recent years are GLP-1 receptor agonists. They work by mimicking the effects of the naturally occurring hormone GLP-1, which helps to regulate blood sugar levels and appetite."

08:37 EDT 3D Systems introduces new materials, technologies at Formnext 2023 - 3D Systems announced it will showcase several new product innovations at Formnext 2023 including materials and printing technologies engineered to help customers meet a variety of application needs. The company is introducing Accura AMX High Temp 300C, SLS 300, a new professional service for C-103, and the DMP Flex 350 Triple - engineered to enable the efficient production of high-quality end-use parts in a breadth of industries including automotive, semiconductor, consumer goods, space, energy, and medical devices. Accura AMX High Temp 300C is planned for general availability in the fourth quarter of 2023. The SLS 300 is available for immediate ordering. The Powder Recycling Station is planned to be available in the first half of 2024. Application development services on C-103 and GRX-810 are currently available through the company's Professional Services delivered by the Application Innovation Group. GRX-810 is currently only available inside the United States. The DMP Flex 350 Triple is currently available for ordering. The new RPM with the 350mm x 350mm x 350mm build box is planned for general availability in July 2024.

08:35 EDT DarioHealth launches new smart blood sugar meter for Apple iPhone 15 - DarioHealth (DRIO) announced the launch of a new smart blood sugar meter for Apple (AAPL) iPhone 15 users to support ongoing engagement with new and existing members. As recently reported, the new iPhone 15 is built with a USB-C charging port, a key element for real-time data capture in Dario's smart blood glucose meter. Dario's new smart blood sugar meter offers iPhone 15 users the same instant connectivity for real-time blood sugar readings as part of their personalized Dario health management experience by giving members a USB-C compatible device.

08:33 EDT Splunk to cut global workforce by 7%, mostly in the U.S. - In a regulatory filing, Splunk announced that the company initiated a plan of reorganization involving approximately 7% percent of the company's global workforce, mostly in the U.S. The company estimates that it will incur approximately $42M in charges, consisting of approximately $37M in future cash expenditures in connection with the Plan related to severance payments, certain retention payments, employee benefits and employee transition costs, as well as approximately $5Min non-cash charges for share-based compensation expense. The company expects substantially all of the actions associated with the Plan to be completed, and substantially all of the associated charges and cash expenditures to be incurred by April 30, 2024, subject to local law and consultation requirements.

08:32 EDT Splunk announces plans to cut global workforce by 7%

08:29 EDT Nautilus Biotechnology appoints Huber as VP of Biochemistry - Nautilus Biotechnology announced the expansion of its research and development senior leadership team with the appointment of Martin Huber, Ph.D., as Vice President, VP, of Biochemistry and Flow Cell Development. Dr. Huber brings to Nautilus over 20 years of experience in biotechnology start-ups both in Europe and the US, most recently as founder, CTO and, ultimately, CEO of Quantapore.

08:26 EDT iBio further expands its AI-powered tech stack with launch of ShieldTx - iBio announced the expansion of its AI-powered technology stack with the launch of ShieldTx, a patent-pending antibody masking technology designed to enable specific, highly targeted antibody delivery to diseased tissue without harming healthy tissue. By adding ShieldTx to its Drug Discovery Platform, iBio uniquely integrates antibody engineering and masking in one accelerated process to potentially overcome the challenges of complex targets, safety, and developability in next-generation antibody discovery and development. The Company used ShieldTx to develop masks for its MUC16-targeted bispecific antibody candidates, which were previously developed using iBio's patented Epitope Steering and EngageTx AI Platforms. "With 40% of approved antibodies working against just 10 targets2, there is significant potential for therapeutic development against additional new targets; but unfortunately, these targets are often difficult and complex, and require new technologies to optimize antibody discovery and development," added iBio's Chief Executive Officer and Chief Scientific Officer, Martin Brenner, DVM, Ph.D. "We are rapidly building an integrated end-to-end platform incorporating the most innovative technologies in machine learning, computational biology, and synthetic biology to enable iBio and our partners to craft the next generation of antibody-based therapeutics against difficult targets and modes of action. ShieldTx is the latest example, following the launch of EngageTx earlier this year."

08:25 EDT Processa Pharmaceuticals announces formation of Oncology Advisory Board - Processa Pharmaceuticals announces the formation of its Oncology Advisory Board featuring key opinion leaders from multiple nationally-recognized institutions. Advisory Board members include: Philip A. Philip, M.D., Ph.D., Henry Ford Cancer Institute; Mitesh Borad, M.D., Mayo Clinic; Patrick Boland, M.D., Rutgers Cancer Institute; Howard Hochster, M.D., F.A.C.P., Rutgers Cancer Institute; Sunil Sharma, M.D., F.A.C.P., Translational Genomics Research Institute.

08:24 EDT ZyVersa Therapeutics announces publication of data on NLRP3 - ZyVersa Therapeutics announces a publication in the peer-reviewed journal, Molecular Neurobiology, demonstrating neuroprotective effects of NLRP3 inflammasome inhibition in a mouse model of MS using a research tool molecule, MCC950. In the paper titled, "Inhibiting the NLRP3 Inflammasome with MCC950 Alleviates Neurological Impairment in the Brain of EAE Mice," the authors studied a mouse model which mirrors MS-like pathology and is commonly used to research MS disease progression. Key findings showed that NLRP3 inflammasome inhibition: Ameliorated pathological changes in the spinal cord and neuron damage in the brain of MS mice. Reduced microglia activation and prevention of its conversion to the M1 phenotype which induces neuroinflammation and neurotoxicity. Reduced activation of astrocytes, which are involved in development of MS. "There is a need for new therapeutic options for MS. Current drug therapies provide symptom control and help to alleviate disability, but they are not neuroprotective," stated Stephen C. Glover, ZyVersa's Co-founder, Chairman, CEO and President. "It is encouraging that the research published in Molecular Neurobiology substantiates our published MS data with Inflammasome ASC Inhibitor IC 100, providing support for its use as a potential therapeutic option. By inhibiting ASC, IC 100 blocks formation of NLRP3 and other types of inflammasomes to block initiation of the inflammatory cascade. Likewise, IC 100 uniquely inhibits ASC specks to attenuate perpetuation of damaging inflammation".

08:23 EDT Information Services wins contract with State of Michigan - Information Services Corporation announced a new contract through its Technology Solutions segment. ISC has secured a $3.2M contract with the State of Michigan for a period of five years, with the option of an extension for up to five more years. The new contract - which includes delivery of a modern, online Uniform Commercial Code System using the Company's RegSys platform - will support service improvement and efficiencies for the State of Michigan. The platform includes robust functionality and will enable 24/7 filing and searching of finance statements, federal tax liens, state tax liens and unemployment liens, enabling greater customer flexibility and enhanced functionality, as well as back-office improvements for State staff.

08:23 EDT Wayfair sees Q4 adjusted EBITDA margin in low single digit range

08:22 EDT Ocuphire Pharma appoints Magrath as CEO, Director - Ocuphire Pharma announced the appointment of George Magrath, M.D., M.B.A., M.S., as Chief Executive Officer and member of the Board of Directors, effective today. Dr. Magrath succeeds Rick Rodgers, M.B.A., Interim Chief Executive Officer and President since April 2023. Rodgers will remain on the company's Board of Directors. Dr. Magrath was most recently the Chief Executive Officer of Lexitas Pharmaceutical Services.

08:21 EDT Stingray Group partners with Air Transat for inflight entertainment - Stingray announced a new partnership with Air Transat. This alliance will provide passengers with an enhanced inflight entertainment experience on Air Transat flights globally. Travellers will have access to a diverse selection of Stingray Music channels, including Hit List, Hot Country, Kids' Stuff, and TikTok Radio. Destination-themed channels such as Breezy Yacht Rock, Suntan Reggae, and Today's Hot Tracks: Latin will also be featured, ensuring a rich and varied listening experience for all. Moreover, passengers will have access to Qello Concerts, a unique service that brings full-length concerts onboard, allowing them to enjoy performances from their favourite artists while in the air.

08:18 EDT Ocular Therapeutix receives FDA agreement under SPA for trial of OTX-TKI - Ocular Therapeutix announced it had received written agreement regarding the overall design from the U.S. Food and Drug Administration, FDA, under a Special Protocol Assessment, SPA, for the Company's ongoing pivotal Phase 3 clinical trial for AXPAXLI, for the treatment of wet age-related macular degeneration, which the Company refers to as the SOL trial. The Company initiated the SOL trial in September 2023 and expects to enroll approximately 300 evaluable wet AMD subjects who are treatment naive in the study eye in the trial. The SOL trial is designed to be a multi-center, parallel-group trial run primarily at U.S. sites, with subjects randomized to one injection of aflibercept or one implant of AXPAXLI followed by supplemental anti-VEGF treatment based on pre-specified criteria. With the agreement under the SPA, the Company will begin enrolling patients in the SOL trial and expects to dose the first subject by year-end.

08:17 EDT Wayfair committed to being adjusted EBITDA profitable 'in good times and bad' - Comments taken from Q3 earnings conference call.

08:16 EDT Jasper Therapeutics appoints Wiggans as Chairperson of the Board of Directors - Jasper Therapeutics announced the appointment of Thomas G. Wiggans, a veteran biopharmaceutical executive, as Chairperson of Jasper's Board of Directors, effective immediately. Bill Lis is stepping down as Chairperson and will retire from the Board in December of this year. Wiggans most recently served as Chairman and CEO of Pardes Biosciences.

08:14 EDT Super League granted new patent allowance by USPTO related to AI - Super League announced the extension of its intellectual property portfolio, following the issuance of its latest patent by the United States Patent and Trademark Office, USPTO, related to AI-driven optimization of live streaming content. Specifically, the company's newest patent pertains to the production and intelligent prioritization of simultaneous perspectives within virtual environments, especially video games, for the purpose of creating compelling experiences and content. "Producing compelling content related to virtual experiences remains a core competency of Super League, and this new patent allows us to further distinguish ourselves by increasing the quality of results while also greatly improving the efficiency of production. We remain fully committed to continued innovation and our stated mission to provide best-in-class immersive and interactive content experiences across the web and metaverse," says David Steigelfest, Super League co-founder and Chief Platform Officer.

08:13 EDT Nuwellis appoints McDonald, Georgiou to board of directors - Nuwellis announced the appointment of Dave McDonald and Archelle Georgiou, MD, to its board of directors, effective November 1, 2023. McDonald serves as Head of Life Science Investment Banking at Lake Street Capital Markets. Dr. Georgiou currently serves as the Chair of the Board of Directors at Children's Hospital and Clinics of Minnesota and Executive in Residence at the University of Minnesota's Carlson School of Management. In addition, Nuwellis announced that Jon Salveson is stepping down from the Board after 10 years of outstanding service.

08:11 EDT Dare Bioscience announces data from Phase 2b RESPOND study - Dare Bioscience and its collaborator Strategic Science & Technologies announced additional positive findings based on further analyses of data from the exploratory Phase 2b RESPOND study that evaluated Sildenafil Cream, 3.6% in women with female sexual arousal disorder, FSAD. The Phase 2b RESPOND study enrolled women with FSAD and included women who had sexual dysfunctions in addition to FSAD. Further analyses of Phase 2b RESPOND study data identified a subset of study participants-women with FSAD as well as women with FSIAD whose primary complaint was arousal dysfunction-that achieved statistically significant and clinically meaningful improvement in the Phase 2b co-primary endpoint of evaluating the efficacy of Sildenafil Cream versus placebo cream as measured by change from baseline to the end of the 12-week double-blind dosing period in the Arousal-Sensation Domain of the Sexual Function Questionnaire. The other co-primary objective of the Phase 2b RESPOND study was to evaluate the efficacy of Sildenafil Cream compared to placebo cream as measured by the change from baseline to the end of the 12-week double-blind dosing period in the score for feeling concerned by difficulties with sexual arousal utilizing the Female Sexual Distress Scale - Desire, Arousal, Orgasm. Analyses of the same subset of women in the Phase 2b RESPOND study demonstrated that the Sildenafil Cream treatment group achieved statistically significant improvement in several FSDS-DAO questions, including regarding guilt, stress, inadequacy, and embarrassment due to their sexual problems.

08:11 EDT NEXT announces strategic partnership with Allstate - NEXT Insurance announced its strategic partnership with Allstate that will combine the companies' expertise in small business insurance to develop and offer innovative and unique new products to a large underserved market, as well as a commitment to deepening its reinsurance relationship with Allianz. The partnerships come with a $265M strategic investment from Allstate and Allianz X.

08:09 EDT Lumine Group acquires Synchronoss' Messaging & NetworkX units - Lumine Group announced that it has completed the acquisition of the Messaging & NetworkX business units from Synchronoss. This will mark Lumine Group's ninth divestiture transaction in the communications and media space. "Lumine Group is an experienced acquirer of corporate divestitures and well positioned to support the future ambitions of these businesses," said Jeff Miller, CEO of Synchronoss. "This acquisition helps ensure a smooth transition for our employees and valued customers, while sharpening Synchronoss' operational focus and bolstering our market presence."

08:08 EDT Michaels officially launches MakerPlace by Michaels - Michaels announced the official launch of MakerPlace by Michaels, the only online marketplace offering handmade goods, artist-led classes, how-to guides, and access to Michaels' assortment of supplies and componentry all through one platform. The launch follows a successful three-month beta test to optimize the experience for shoppers and sellers alike. "The launch of MakerPlace by Michaels deepens our ability to support customers in all of their creative pursuits, whether that be learning new skills, discovering handmade goods, or growing their own handmade business," said Ashley Buchanan, Chief Executive Officer at Michaels. "MakerPlace provides a new way to buy and sell unique handmade art, gifts, goods and classes while empowering our customers to directly support or become handmade sellers themselves."

08:07 EDT Ceridian co-CEO Leagh Turner departs - Ceridian announced that Leagh Turner, Co-CEO and member of the Board of Directors, will depart the company on November 10, 2023 to become CEO of Coupa Software. David Ossip will continue to lead the company as Chair and sole CEO.

08:07 EDT vTv Therapeutics announces sale of shares in Reno Pharmaceuticals for $4.4M - vTv Therapeutics announced that it has entered into a common stock repurchase agreement with Reneo Pharmaceuticals, Inc. through which Reneo has purchased all of its common stock that was granted to vTv under the Reneo License Agreement for total proceeds to vTv of approximately $4.4 million. "The proceeds from the sale of our Reneo stock will provide vTv with important financial support as we continue our preparations for the launch of the cadisegliatin Phase 3 program in T1D. We remain in active discussions related to the financing, partnering and/or licensing of cadisegliatin," said Paul Sekhri, President and Chief Executive Officer of vTv Therapeutics. "We are excited about the therapeutic potential of mavodelpar and look forward to Reneo's upcoming data readout. If mavodelpar is successful, it could provide significant upside to vTv and our shareholders through potential milestone payments and commercial royalties."

08:03 EDT Purple Innovation and RemWave announce partnership - Purple Innovation and RemWave announced a partnership to make restorative sleep more accessible to millions of customers. This partnership makes Purple the first-to-market distributor for the most advanced non-wearable sleep device available today. RemWave is a convenient, non-contact sleep product that tracks and monitors sleep. RemWave measures 6-inches in diameter, and can be placed easily underneath any bed. It can track up to two different people's sleep with two devices underneath the bed.

07:59 EDT Snail says ARK: Survival Ascended becomes top selling game on Steam - Snail announced the newly released ARK: Survival Ascended was the #1 top selling game on Steam on launch day, October 25th. This latest installment of the ARK franchise has completely recreated and redesigned the artwork and worlds of ARK to take advantage of the latest in video game technology, Unreal Engine 5.

07:55 EDT UPT to acquire Patriot Transportation for $16.26 per share in cash - Patriot Transportation Holding announced an agreement under which United Petroleum Transport will acquire all of the outstanding shares of Patriot common stock for $16.26 per share in cash. The transaction values Patriot Transportation at approximately $65.9 million, including assumed cash and debt. The combination advances UPT's and Patriot's shared vision to become a top five bulk tank carrier by revenue with combined revenues in excess of $200 million and to become the premier tank truck company in the southern United States. Upon completion of the transaction, the combined company will have over 1,000 drivers servicing markets from Arizona to Florida covering 11 states with over 30 terminals. The companies have strong market brands and operate with a similar culture focused on safety and quality customer service. To capitalize on its strong brand and reputation, UPT will continue to operate Patriot's business through Patriot's subsidiary, Florida Rock & Tank Lines. UPT will utilize the combined company strength, the high-quality employees and large regional and national customer base to strategically grow the business. Florida Rock serves the southeastern United States as a premier bulk tank carrier specializing in hauling primarily petroleum-related products and other liquid and dry bulk commodities. One of the largest regional tank truck carriers in North America, Florida Rock operates in Florida, Georgia, Alabama, and Tennessee with 17 terminals and six satellite locations. The transaction, which has been unanimously approved by Patriot's Board of Directors, is subject to the satisfaction of other customary closing conditions, including the approval of Patriot's shareholders. Shareholders owning 26.6% of the voting power of Patriot's common stock have agreed to vote in favor of the merger, subject to customary exceptions. Upon completion of the transaction, which the parties expect will occur by early 2024, Patriot will become a private company and delist from the NASDAQ Global Select Market. UPT has obtained a customary financing commitment from an established lending institution pursuant to which the lender will provide financing that, together with other available sources, is expected to be sufficient to fund the merger consideration and other obligations under the merger agreement. The definitive merger agreement includes a 30-day "go-shop" period that will expire on December 1, 2023, which permits Patriot and its representatives to actively solicit and consider alternative acquisition proposals. There can be no assurance that this process will result in a superior proposal, and the Company does not intend to disclose developments with respect to the go-shop process unless and until it determines such disclosure is appropriate or is otherwise required.

07:50 EDT Marimaca Copper appoints Bruno Lagomarsino as non-executive director - Marimaca Copper (MARIF) announces the appointment of Giancarlo Bruno Lagomarsino as Non-Executive Director with immediate effect. Most recently, Bruno Lagomarsino was Senior VP of Capstone Copper (CSCCF) in charge of its Chilean operations.

07:49 EDT Abeona Therapeutics announces new employee inducement grants - Abeona Therapeutics announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On October 31, 2023, the Compensation Committee of Abeona's Board of Directors granted restricted stock equity awards as a material inducement to employment to five individuals hired by Abeona, which equity awards relate to, in the aggregate, up to 59,600 restricted shares of Abeona common stock.

07:48 EDT Guru Organic Energy shares update on recent Amazon Prime day performance - GURU Organic Energy (GUROF) shared an update on its recent Amazon (AMZN) Prime Day performance, and on its continuing efforts to grow the wholesale club channel sector. Amazon's fall Prime Day event, which took place on October 10 and 11, was a resounding success for the Company. GURU achieved over 370% growth in sales in Canada and over 130% growth in the U.S., compared to the same promotion last year. Carl Goyette, President and CEO of GURU, stated: "These operational achievements underscore our determination to drive sales across all sectors of our business, including the online and wholesale club channels, which carry huge revenue potential. Over the last year, we've evolved our marketing and sales strategies to cater more closely to our consumers seeking Good Energy and we're very pleased with the results. We look forward to continuing this momentum with a planned series of marketing activities, including the launch of our Fruit Punch and another new great-tasting innovation coming soon in the U.S."

07:45 EDT Newcore Gold commissions updated preliminary economic study for Enchi Gold - Newcore Gold announces it has engaged the independent engineering consultants Lycopodium, Micon International Limited and SEMS Exploration to prepare an updated National Instrument 43-101 Preliminary Economic Assessment study for the Company's 100%-owned Enchi Gold Project in Ghana. Newcore is targeting completion and announcement of the results of the study by the end of H1 2024. Luke Alexander, President & CEO of Newcore stated, "We believe updating our PEA is an important step in continuing to advance the development of our Enchi Gold Project in Ghana. The update will incorporate the current Mineral Resource Estimate that was announced earlier this year, updated cost estimates, as well as the significant metallurgical testwork that has been completed on the Project since the last economic study was completed in 2021.This low-cost de-risking work will continue to advance the development of our district-scale Enchi Gold Project, showcase its potential as an open pit, heap leach operation, while also providing an underpinning of value for Newcore Gold."

07:45 EDT StateHouse issues consideration for increased interest in Haight-Ashbury - StateHouse Holdings announced that the Company has completed the issuance of shares related to its acquisition of a further 29.9% interest in FGW Haight, a cannabis dispensary in San Francisco's historic Haight-Ashbury district as previously announced on February 15, 2022. The FGW Acquisition has increased the Company's interest in Harborside San Francisco to 80%. StateHouse acquired the additional interest in FGW through the execution of a securities purchase agreement following the previously announced acquisition of 50.1% interest in FGW that closed on December 18, 2020. Pursuant to the Agreement, StateHouse has issued 1,170,584 common shares in the Company at a price of US $1.50 per share in consideration for the remaining ownership interest. The Company also retains the right of first refusal to purchase, in its discretion, in whole or in part and in one or more closings, the remaining 20% of FGW, subject to regulatory approvals.

07:43 EDT GigaCloud completes acquisition of Noble House - GigaCloud Technology announced that it has completed the previously announced asset acquisition of Noble House Home Furnishings, a leading B2B distributor of indoor and outdoor home furnishings, for approximately $85 million, subject to customary purchase price adjustments. The acquisition is funded entirely with cash on hand. The assets acquired from Noble House include, but not limited to, inventory, warehouse leases, websites and domain names, trademarks, tradenames, patents, customer contracts, sales channels and other assets. "We could not be more thrilled to complete our asset acquisition of Noble House, which aligns with our core strategy of building a diverse, large-scale B2B marketplace with high-quality, differentiated products," said Larry Wu, Founder, Chairman, and Chief Executive Officer of GigaCloud. "The acquisition adds significant warehouse space, exceeding 2.3 million square feet, and strengthens our distribution, inventory, and customer base. We believe by integrating our B2B marketplace with Noble House's product design and quality control capabilities into our offerings, the growth of our marketplace will accelerate. Transactions in our marketplace empower Noble House suppliers to boost margins through our supplier-fulfilled retailing business model."

07:42 EDT Clearside Biomedical completes recruitment in ODYSSEY Phase 2b trial - Clearside Biomedical announced the completion of recruitment in its ODYSSEY Phase 2b clinical trial, a randomized, double-masked, parallel-group, active-controlled, multi-center study in participants with neovascular age-related macular degeneration. ODYSSEY is evaluating the safety and efficacy of CLS-AX, a highly potent tyrosine kinase inhibitor delivered directly to the site of disease via Clearside's SCS Microinjector. Following the completion of recruitment, final participants will be randomized to the CLS-AX treatment arm or the aflibercept comparator arm by the middle of December 2023. The Company expects to report topline data in the third quarter of 2024. "The completion of recruitment in ODYSSEY is a critical achievement for Clearside as we strive to bring an improved therapy to the millions of individuals living with wet AMD, a common cause of legal blindness in individuals over age 55," said, George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer. "The efficacy and safety results from the study will guide the path forward for our pivotal Phase 3 development program for CLS-AX. We would like to thank the clinical trial participants, investigators, and sites whose significant interest in CLS-AX drove strong recruitment for the study as we pursue the common goal of improving treatment for wet AMD."

07:41 EDT Jonathan Milner suspends 'Vote AGAINST' campaign on Abcam acquisition - onathan Milner, the founder and one of the largest investors in Abcam (ABCM) with ownership of 6.16% of the Company, issued the following statement in relation to the proposed acquisition of Abcam by Danaher Corporation (DHR) or its affiliates. "After extensive feedback from the majority of Abcam's shareholders, I have today decided to suspend my "Vote AGAINST" campaign. It has become clear that a significant majority intend to support Danaher's acquisition of Abcam and I respect this decision and will not stand in the way of the deal. Although this outcome is not what I envisioned, I accept the result and wish Abcam and Danaher all the best for their future. My sincere gratitude goes to everyone who supported my campaign over the last few months, especially to my shadow Board nominees: your bravery and loyalty have been deeply appreciated. A special thanks also goes to my team of advisors who, acting with integrity and honesty, ensured every shareholder's voice was heard. Since the start of my campaign, Abcam's share price increased significantly and, despite the final outcome, I sincerely believe that our campaign has shown that it is possible to stand up to, and call out, an ineffective Board and Management who displayed disregard for the interests of shareholders. It also drew attention to key metrics, governance issues, and the performance of Executive Directors. It is disappointing that, confronted with these facts, Abcam's Board and leadership team decided to simply put the Company up for sale and accept a subpar offer, at the expense of loyal and long-term shareholders. I hope that my actions will inspire shareholders in other companies to hold their Boards to account. I extend my heartfelt best wishes to the dedicated staff and loyal customers of Abcam. May they find continued success under the new ownership of Danaher."

07:40 EDT Kazia Therapeutics provides update from Phase 2 clinical trial of paxalisib - Kazia Therapeutics provided a preliminary update from the ongoing investigator-initiated Phase 2 clinical trial, or NCT04906096, evaluating paxalisib as monotherapy treatment in patients with relapsed/refractory primary central nervous system lymphoma, or r/r PCNSL. This is an open-label, Phase 2 clinical trial, led by Lakshmi Nayak, of the Dana-Farber Cancer Institute in Boston, MA. Eligible patients with r/r PCNSL will be administered paxalisib as monotherapy for up to 24 months, in an initial dosing regimen of 60mg daily, which is similar to the dosing regimen used for paxalisib clinical trials in other adult brain cancers. The objectives of the study are to assess the clinical efficacy and safety of paxalisib in up to twenty-five patients with r/r PCNSL based on objective response rate, or ORR, duration of response, or DOR, progression-free survival, or PFS, and overall survival, or OS. To date, fourteen patients have been enrolled in the study. Clinical activity has been preliminarily observed in enrolled patients, including partial responses and stable disease. Although early clinical activity was observed in some patients, several heavily pretreated r/r PCNSL patients experienced treatment-related adverse events consistent with those previously reported with paxalisib, that resulted in dose reductions and, in some cases, early termination from the study. As such, the protocol is being optimized by the investigator to initiate starting doses at 15mg twice a day or 30mg once a day with the goal of improving the durability of clinical benefit and overall tolerability.

07:39 EDT Nephros hires Krandel as Chief Financial Officer - Nephros (NEPH) announced the appointment of Judy Krandel as Chief Financial Officer, CFO, effective today. In this role, Krandel will be responsible for directing the company's finances and working closely with the Chief Executive Officer, CEO, and Board of Directors to develop and execute Nephros's long-term strategy. Prior to joining Nephros, Krandel served as the Chief Financial Officer of Recruiter.com (RCRT)

07:34 EDT TG Therapeutics expects cash to fund operations into cash flow positivity - Cash, cash equivalents and investment securities were $229.2 million as of September 30, 2023. We anticipate that our cash, cash equivalents and investment securities as of September 30, 2023, combined with the projected revenues from BRIUMVI, will be sufficient to fund our planned operations into cash flow positivity based on the current operating plan.

07:31 EDT ParaZero announces Chell as joined the company as a special advisor - ParaZero Technologies (PRZO) announced that Cameron Chell has joined the ParaZero team as special advisor. Chell will help facilitate business development efforts in the drones' market as well as the defense field. Chell is the co- founder and CEO of Draganfly Innovations (DPRO).

07:30 EDT Bitfarms mined 398 bitcoin in October - October production of 398 BTC declined 3.2% from the 411 BTC earned in September as network difficulty increased 9.4% in October compared to 2.7% in September, reflecting the continuing strong demand for miners going into the 2024 halving. For the ten months ended October 31st, network difficulty increased 76.6% while the BTC price was up approximately 107.8%, resulting in a 23.3% improvement in production economics as measured by USD/TH/day. "In October, we increased our hashrate to 6.3 EH/s as we completed energization of our Baie-Comeau, Quebec facility at 11 MW and boosted Rio Cuarto from 51 MW to 54 MW. We ended October with 240 MW of operating capacity, up 31% from a year ago," said Geoff Morphy, CEO of Bitfarms. "With long-term and low-cost energy contracts totaling 574 MW, we still have significant room to expand our portfolio and build new farm infrastructure that would more than double our current 240 MW in production."

07:29 EDT Revolution Medicines says independent proxy recommend 'FOR' EQRx acquisition - Revolution Medicines (RVMD) announced that leading independent proxy advisory firms, Institutional Shareholder Services and Glass Lewis & Co, have recommended Revolution Medicines stockholders vote "FOR" the issuance of Revolution Medicines shares in the previously announced all-stock acquisition of EQRx (EQRx) at the special meeting of stockholders scheduled for November 8, 2023. In their respective reports, ISS and Glass Lewis view the proposed transaction as favorable to Revolution Medicines stockholders. The acquisition will add the significant cash resources held by EQRx and strengthen Revolution Medicines' balance sheet, allowing the company to sustain and retain control of its research and development plans for its RAS Inhibitor pipeline. "We are pleased that ISS and Glass Lewis support our proposed acquisition of EQRx and the significant long-term value opportunity this compelling transaction provides to our stockholders," said Mark A. Goldsmith, M.D., Ph.D., Revolution Medicines, chief executive officer and chairman. "The addition of approximately $1.1 billion to our balance sheet will increase our financial strength and enable robust investments to advance the clinical development of RMC-6236, our RASMULTI Inhibitor, RMC-6291, our RASG12C Inhibitor, and RMC-9805, our RASG12D Inhibitor. This transaction will also increase our capacity to develop our growing RAS Inhibitor pipeline in order to deliver high-impact targeted medicines to an even larger range of patients with RAS-addicted cancers." The company also today announced the final exchange ratio for the EQRx acquisition. Each share of common stock of EQRx issued and outstanding immediately prior to the merger will be converted into the right to receive 0.1112 shares of common stock of Revolution Medicines. If the transaction is completed, Revolution Medicines expects to issue approximately 55 million shares of its common stock in connection with the merger. The company estimates that the acquisition will add approximately $1.1 billion in net cash proceeds, after estimated post-closing EQRx wind-down and transition costs, or approximately $20 per share of common stock issued in connection with the merger.

07:27 EDT U.S. Silica announces price increases on Industrial and Specialty Products - U.S. Silica Holdings announced that its Industrial and Specialty Products segment will increase prices for most of its non-contracted silica, aplite, diatomaceous earth, clay, perlite, and cellulose products used primarily in glass, filtration, foundry, paints, coatings, elastomers, roofing, chemicals, recreation, building products, renewable diesel, industrial oil, and other applications. Price increases will range up to 20% depending on the product and grade and go into effect for shipments beginning January 1, 2024. These price increases are necessary to help offset significant and continuing cost increases in labor, transportation, materials, and manufacturing costs.

07:26 EDT Osino Resources announces assay results from infill drilling at Twin Hills - Osino Resources provided an update on the recently completed infill drill program at the Twin Hills Gold Project including the best hole drilled at the Project to date with an intercept of 61m at 3.21g/t. Osino remains focused on the financing and pre-construction activities at Twin Hills, as well as closely spaced infill drilling of the initial starter pits to validate modelling and de-risk initial production. Dave Underwood, Osino's VP Exploration commented: "The systematic, tightly spaced infill drilling at Bulge is producing some very positive results with a best so far of 61m @ 3.21g/t, including 1m @ 106g/t. This result indicates that there are some small but very high-grade shoots within the Twin Hills deposit, that could enhance the resource numbers and production gold grade down the line. The drill program is being carried out at grade control spacing thus significantly de-risking the early production at the Bulge pit and further validates the modelling methodology used to derive the Twin Hills mineral resource numbers. A similar exercise at the Twin Hills Central portion of the pit was successfully completed in 2022 which validated the wider spaced modelling and resulted in a significant increase in grade over that mineral resource block without a loss in contained metal. We are very pleased to see that this effect seems to be playing out at the Bulge portion of the Twin Hills deposit as well. Once we have received all the outstanding results, we will quantify this data and incorporate it into an updated Twin Hills mine plan." A total of 11,427m from 110 reverse circulation holes were completed within a block of 160m x 110m. These holes were drilled on a 12.5m x 12.5m grid spacing and ranged in depth from 60m to 120m. Drilling to a datum, the program conforms to the existing inclined drill pattern with holes drilled at minus 60 degrees dip towards the south-southeast. The drill program covers the Bulge year one starter pit hosting sub-cropping mineralisation, which plunges north-northeast to form the main ore shoot. The infill program results will drive an internal review of geological and resource modelling techniques and parameters utilised in the generation of the latest MRE comprising 2.94moz at 1.08 g/t and 0.25moz at 1.10g/t. Pending the remaining assay results, the program is on track to achieve its ultimate objective of confirming and upgrading the next MRE iteration. An additional infill drill program has commenced at the Clouds and Twin Hills Central pits with the aim of converting the first 2 years of mining from Indicated to Measured category, thereby substantially de-risking the first 2 years of ore mining, which represents the expected finance payback period plus a healthy margin.

07:24 EDT SpringWorks Therapeutics to present additional data from Phase 3 DeFi trial - SpringWorks Therapeutics announced the presentation of additional data from the Phase 3 DeFi trial at the 2023 Connective Tissue Oncology Society Annual Meeting, being held November 1-4, 2023. These data demonstrate the impact of nirogacestat, an investigational gamma secretase inhibitor, on physical and role functioning in adults with desmoid tumors. Data from the DeFi trial demonstrated statistically significant and clinically meaningful improvements across all primary and key secondary endpoints and were previously presented at leading medical congresses and published in the March 9, 2023 edition of the New England Journal of Medicine.

07:23 EDT DiamondRock expects to spend $100M at its hotels in FY23 - The Company invested approximately $67.1M in capital improvements at its hotels during the nine months ended September 30. The Company expects to spend $100M on capital improvements at its hotels in 2023. Significant projects in 2023 include The Dagny: The Company completed a comprehensive renovation to rebrand the Hilton Boston Downtown/Faneuil Hall as The Dagny, an independent lifestyle hotel, during the Q3; Salt Lake City Marriott: The Company completed a renovation of the guestrooms during the Q3; Hilton Burlington Lake Champlain: The Company commenced a repositioning of the hotel to rebrand it as a Curio Collection hotel. The repositioning is expected to be completed in the summer of 2024 and includes a new restaurant concept by a well-known, award-winning chef.

07:21 EDT Tilray's SweetWater Brewing launches special-edition 420 IPA - SweetWater Brewing Company announced a new partnership with one of the world's largest and best Aquariums, Georgia Aquarium, supporting their mission of inspiring awareness and preservation of oceans and aquatic animals worldwide. As part of the partnership, SweetWater has released special-edition 12-packs and 12-ounce cans of its flagship beer, 420 Extra Pale Ale, featuring the Aquarium's branding and ocean-themed art. SweetWater will donate proceeds from the special-edition 420 IPA sales to Georgia Aquarium.

07:19 EDT Kraft Heinz names Pedro Navio EVP & President, North America - As part of its mission to accelerate profitable growth and to lead the future of food, the Company has named its new President of the North America Zone, elevated key roles to a global level, and restructured its International Zone. These changes preserve the Company's local agility while leveraging support, expertise, and resources from its scale. First, Pedro Navio has been named EVP & President, North America, and will succeed Carlos Abrams-Rivera who, as previously announced, will serve as the Kraft Heinz CEO. Navio has been with Kraft Heinz since 2017, and is currently President, Taste, Meals, and Away From Home, in North America. Prior to Kraft Heinz, Navio spent more than 15 years at Red Bull, most recently as CEO of Latin America. Second, the Company is establishing global leadership teams for its Growth and Omnichannel functions. Investing in these disciplines on a global level provides the structure and support to leverage centralized expertise and resources. It also helps drive growth and disruptive innovation across the business while optimally servicing customers and consumers. Lastly, to further drive international growth, the Company is dividing its international business into three zones. Recognizing these markets require different sets of strategies and skills, the new structure provides the necessary focus and resources to optimize growth potential.

07:11 EDT Trimble names Phil Sawarynski as CFO, effective May 2024 - Trimble announced on its third quarter fiscal 2023 earnings call that CFO David Barnes will retire from the company in May 2024. The company has named Phil Sawarynski, Vice President of Treasury, Corporate Development and Co-Lead of Trimble Ventures, its new CFO effective May 2024. Barnes and Sawarynski will work together over the next six months to ensure a seamless transition

07:06 EDT Amarin expects cash to support continued operations, including European launch - Amarin continues to make progress on reducing operating expenses and managing its cash position and on-track to deliver $40 million of annual savings based on the reduction in force announced in July 2023. With the recent cash preservation initiatives, Amarin reiterates its belief that current cash and investments and other assets are adequate to support continued operations, including European launch activities.

07:04 EDT Merck: FDA approves Keytruda in combination with gemcitabine and cisplatin - Merck announced that the U.S. FDA has approved KEYTRUDA, Merck's anti-PD-1 therapy, in combination with gemcitabine and cisplatin, for the treatment of patients with locally advanced unresectable or metastatic biliary tract cancer. The approval was based on results from the Phase 3 KEYNOTE-966 trial, in which KEYTRUDA plus chemotherapy demonstrated a statistically significant improvement in the study's primary endpoint of overall survival, reducing the risk of death by 17% compared to chemotherapy alone at the trial's pre-specified final analysis for OS. Median OS was 12.7 months for KEYTRUDA plus chemotherapy versus 10.9 months for chemotherapy alone. This approval marks the sixth indication for KEYTRUDA in gastrointestinal cancers.

06:50 EDT Estee Lauder announces FY25, FY26 profit recovery plan - Given the slower-than-expected pace of recovery, the Company accelerated and expanded its profit recovery plan to preserve the Company's expectation to progressively rebuild its profit margins in fiscal years 2025 and 2026. The plan is anticipated to be substantially in place in the beginning of calendar 2024 to enable the realization of expected benefits in fiscal years 2025 and 2026, the majority of which are expected to benefit fiscal 2025 operating profitability. This plan is designed to target specific areas of the Company's business to improve gross margin and lower certain operating expenses over the next two fiscal years, while further investing in key consumer-facing activities. For example, the Company intends to further reduce obsolescence and streamline overhead costs through enhancements to its global and local processes. The Company expects to drive $800 million to $1 billion of incremental operating profit through the initiatives under this plan. The Company remains optimistic about the prospects and future growth opportunities in global prestige beauty, the re-activation of its multiple engines of growth and the continued investment in its strong brand equity, and believes it is well-positioned to drive diversified growth across its portfolio. The Company continues to monitor the effects of the global macro environment, including the risk of recession; currency volatility; inflationary pressures; supply chain challenges; social and political issues; regulatory matters, including the imposition of tariffs and sanctions; geopolitical tensions; and global security issues. The Company is also mindful of inflationary pressures on its cost base and is monitoring the impact on consumer preferences.

06:47 EDT Estee Lauder provides FY24 outlook - The Company entered the fiscal year with a focus on re-establishing balanced and profitable long-term growth across regions, product categories, brands and channels. The Company is lowering its outlook to reflect the slower pace of recovery in net sales and margins as a result of incremental external headwinds. In mainland China, the expected growth rate of overall prestige beauty has slowed. To reflect this trend, the Company is lowering its fiscal 2024 expectations for mainland China and Asia travel retail. Amid this headwind, the Company continues to expect to reset retailer inventory in Asia travel retail by the end of the third quarter of fiscal 2024. This, combined with the potential risks of further business disruptions in Israel and other parts of the Middle East as well as currency headwinds, are increasing the pressure on the Company's fiscal 2024 financial results. With its revised outlook, the Company still anticipates to progressively improve performance in the second half of fiscal 2024. The Company also plans to continue to strategically invest in consumer-facing activities, where appropriate, in areas to support recovery, share gains and long-term profitable growth. These investments include innovation, advertising, growth of its emerging markets and the completion of its first manufacturing facility in Asia, located in Japan, to support the development of the regionalization of the supply chain in the Asia/Pacific region. The full year outlook reflects the following assumptions and expectations: A return to net sales growth in the second half of fiscal 2024. Full-year gross margin expansion primarily driven by strategic price increases, discount reductions and lower obsolescence charges, largely offset by manufacturing under-absorption. Contraction in the first half of fiscal 2024 is expected to be more than offset by expansion in the second half. Progressive operating margin improvement throughout the second half of fiscal 2024 due to the cadence of the improvement of the Asia travel retail business and in mainland China. Full year effective tax rate of approximately 28%.

06:19 EDT Macau reports October casino revenue up 400.2% to 19.5B patacas - Macau's gaming bureau reported October gross revenue from games of fortune in the region was up 400.2% year-over-year to 19.501B patacas. Publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS), MGM Resorts (MGM), Wynn Resorts (WYNN) and Melco Resorts (MLCO). Reference Link

06:15 EDT Trane CEO says 'bookings at an all-time high' - "Focused execution of our purpose-driven strategy continues to deliver industry-leading results and enable high levels of business reinvestment for future growth," said Dave Regnery, chair and CEO, Trane Technologies. "With bookings at an all-time high, we continue to see robust customer demand for our sustainable products and services, with particular strength across our commercial HVAC businesses globally. Our strong operating performance and robust backlog give us confidence in once again raising our full-year revenue and adjusted EPS guidance and provide visibility to solid growth in 2024 as well. With our leading innovation, resilient portfolio and talented team, Trane Technologies is uniquely positioned to deliver superior growth and differentiated shareholder returns over the long term."

06:14 EDT Toyota still sees FY group vehicle sales 11.4M units

06:10 EDT Li-Cycle adopts limited duration shareholder rights plan - Li-Cycle Holdings announced that its Board of Directors has adopted a limited duration shareholder rights plan. The Rights Plan is intended to protect the long-term interests of Li-Cycle and Li-Cycle's shareholders and to enable them to realize the full potential value of their investment in the Company. The Rights Plan is designed to protect against unequal treatment of the Company's shareholders and reduce the likelihood that any person or group will gain control of, or exert significant influence over, Li-Cycle, including through open market accumulations, without appropriately compensating Li-Cycle's shareholders for control. The Rights Plan also helps ensure that the Board has sufficient time to make informed, deliberate decisions and take actions that are in the best interests of Li-Cycle. The Rights Plan applies equally to all current and future shareholders of Li-Cycle. The Rights Plan is not intended to prevent or interfere with any action with respect to Li-Cycle that the Board determines to be in the best interests of the Company. The Rights Plan will operate similarly to rights plans adopted by other companies publicly listed in the United States. Pursuant to the Rights Plan, Li-Cycle will issue one right for each common share of the company outstanding as of the close of business on November 10, 2023. While the Rights Plan is effective immediately, the rights generally will become exercisable only if an applicable person or group acquires beneficial ownership of 20% or more of Li-Cycle's outstanding common shares in a transaction not approved by the Board. In that situation, each holder of a right will have the right to purchase, for the purchase price of $12.50, a number of common shares of the company having a then-current market value of twice the purchase price. In addition, at any time after an applicable person or group acquires 20% or more of the company's common shares, the Board may, at its option, deem all or part of the rights exercised at a ratio of one common share for each outstanding right for a nil purchase price per right. The Rights Plan has a 364-day term and will expire on October 30, 2024.

06:10 EDT Northrop Grumman awarded $542.93M Navy contract modification - Northrop Grumman was awarded a $542.93M cost-plus-fixed-fee, firm-fixed-price, fixed-price incentive modification to a previously awarded contract. This modification provides for the production and delivery of MQ-4C Triton Unmanned Aircraft System Low-Rate Initial Production Lot Six, to include three unmanned aircraft, or UA, for the Navy; one UA for the government of Australia; and one main operating base for the Navy, as well as associated support and related technical and administrative data. Work is expected to be completed in January 2028. FY23 aircraft procurement funds in the amount of $411.38M; FY22 aircraft procurement funds in the amount of $971,678; and Royal Australian Air Force cooperative funds in the amount of $40M will be obligated at the time of award, $971,678 of which will expire at the end of the current fiscal year. Naval Air Systems Command is the contracting activity.

06:05 EDT DuPont says Q4 underlying consumer electronics demand will be similar to Q3 - "As we look at the fourth quarter, underlying consumer electronics demand is expected to be similar with the third quarter and reflected by stable order rates from our customers, with some sequential sales lift expected in Semiconductor Technologies," Koch continued. "However, versus our prior guidance, we are seeing additional channel inventory destocking and slower industrial water demand in China."

05:37 EDT Nio delivers 16,074 vehicles in October - Nio announced its October delivery results. Nio delivered 16,074 vehicles in October, increasing by 59.8% year-over-year. The deliveries consisted of 11,086 premium smart electric SUVs, and 4,988 premium smart electric sedans. Cumulative deliveries of NIO vehicles reached 415,623 as of October 31.

05:30 EDT Industrial Tech Acquisitions II, Next Renewable Fuels terminate merger pact - Industrial Tech Acquisitions II announced that ITAQ and Next Renewable Fuels have mutually agreed to terminate their previously announced agreement and plan of merger, effective as of October 31 by entering into a mutual termination and release agreement among ITAQ, ITAQ Merger Sub Inc., Next and Industrial Tech Partners II, which is ITAQ's sponsor. In April, in connection with an amendment to the company's certificate of incorporation to extend the date by which the company must complete its initial business combination, public stockholders holding 15,901,113 public shares exercised their right to redeem such shares for a pro rata portion of the funds in the trust account. As a result, $165,137,380.09 was removed from the trust account to pay such holders, and the company currently has 1,348,887 public shares outstanding.

05:07 EDT Li Auto delivers 40,422 vehicles in October - Li Auto announced that the company delivered 40,422 vehicles in October, representing an increase of 302.1% year over year. Monthly deliveries exceeded the 40,000 milestone for the first time, and the cumulative deliveries of Li Auto vehicles in 2023 reached 284,647 as of the end of October.